| 1 |
Wang D, Zhang W, Zhang X, Li M, Wu Q, Li X, Zhao L, Yuan Q, Yu Y, Lu J, Zhao J, Dong Z, Liu K, Jiang Y. Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase. Mol Carcinog 2023;62:517-31. [PMID: 36645220 DOI: 10.1002/mc.23503] [Reference Citation Analysis]
|
| 2 |
Zheng SJ, Zheng CP, Zhai TT, Xu XE, Zheng YQ, Li ZM, Li EM, Liu W, Xu LY. Development and Validation of a New Staging System for Esophageal Squamous Cell Carcinoma Patients Based on Combined Pathological TNM, Radiomics, and Proteomics. Ann Surg Oncol 2023;30:2227-41. [PMID: 36587172 DOI: 10.1245/s10434-022-13026-6] [Reference Citation Analysis]
|
| 3 |
ArefNezhad R, Rezaei-Tazangi F, Roghani-Shahraki H, Goleij P, Zare N, Motedayyen H, Aghazadeh E. Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell Biol Int 2023;47:714-9. [PMID: 36718080 DOI: 10.1002/cbin.11991] [Reference Citation Analysis]
|
| 4 |
Li L, Lv L, Xu J, He Q, Chang N, Cui Y, Tao Z, Zhu T, Qian L. RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6. IJMS 2023;24:5586. [DOI: 10.3390/ijms24065586] [Reference Citation Analysis]
|
| 5 |
Zeng Y, Li QK, Roy S, Mills JC, Jin RU. Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus. Front Cell Dev Biol 2023;11. [DOI: 10.3389/fcell.2023.1151790] [Reference Citation Analysis]
|
| 6 |
Sun L, Kang X, Wang C, Wang R, Yang G, Jiang W, Wu Q, Wang Y, Wu Y, Gao J, Chen L, Zhang J, Tian Z, Zhu G, Sun S. Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma. Cell Discov 2023;9:28. [PMID: 36914617 DOI: 10.1038/s41421-023-00532-4] [Reference Citation Analysis]
|
| 7 |
Wang Q, Zhang X, Zhong Y, Wei S, Li L, Wei W, Liu F, Li Y, Wang S. Clinical characteristics and changing trajectories of esophageal cancer and gastric cancer in China from 2010 to 2019: An analysis of a hospital-based database of 24,327 patients. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1126841] [Reference Citation Analysis]
|
| 8 |
Yang W, Yang Y, Ma X, Ma M, Han B. Surgery and postoperative radiotherapy affect the prognosis of esophageal cancer: A SEER analysis. Medicine (Baltimore) 2023;102:e32925. [PMID: 36862870 DOI: 10.1097/MD.0000000000032925] [Reference Citation Analysis]
|
| 9 |
Xu X, Jiang F, Guo Y, Chen H, Qian J, Wu L, Xie D, Chen G. Clinical-Pathological Characteristics of Adenosquamous Esophageal Carcinoma: A Propensity-Score-Matching Study. JPM 2023;13:468. [DOI: 10.3390/jpm13030468] [Reference Citation Analysis]
|
| 10 |
Deboever N, Hofstetter WL. From NLR to TIN: What Can't Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer? Ann Surg Oncol 2023;30:1295-6. [PMID: 36607524 DOI: 10.1245/s10434-022-12961-8] [Reference Citation Analysis]
|
| 11 |
Sugawara K, Fukuda T, Kishimoto Y, Oka D, Yoshii T, Hara H, Uemura Y, Kawashima Y, Kanda H, Motoi N. Influences of intratumoral heterogeneity on assessment of tumor microenvironment in esophageal squamous cell carcinoma. Cancer Sci 2023;114:1180-91. [PMID: 36424361 DOI: 10.1111/cas.15665] [Reference Citation Analysis]
|
| 12 |
Cabalag CS, Prall OWJ, Ciciulla J, Galea LA, Thio N, Jayawardana M, Leong TYM, Milne JV, Fujihara KM, Chong L, Hii MW, Arnau GM, Neeson PJ, Phillips WA, Duong CP, Clemons NJ. Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer. Ann Surg Oncol 2023;30:1614-25. [PMID: 36183015 DOI: 10.1245/s10434-022-12562-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Nicholas B, Bailey A, McCann KJ, Wood O, Walker RC, Parker R, Ternette N, Elliott T, Underwood TJ, Johnson P, Skipp P. Identification of neoantigens in oesophageal adenocarcinoma. Immunology 2023;168:420-31. [PMID: 36111495 DOI: 10.1111/imm.13578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Noordzij IC, Hazen ML, Nieuwenhuijzen GAP, Verhoeven RHA, Schoon EJ. Endoscopic therapy replaces surgery for clinical T1 oesophageal cancer in the Netherlands: a nationwide population-based study. Surg Endosc 2023. [PMID: 36849563 DOI: 10.1007/s00464-023-09914-x] [Reference Citation Analysis]
|
| 15 |
Nose Y, Makino T, Tatsumi M, Tanaka K, Yamashita K, Noma T, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Nakajima K, Eguchi H, Doki Y. Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes. Br J Cancer 2023. [PMID: 36841907 DOI: 10.1038/s41416-023-02151-y] [Reference Citation Analysis]
|
| 16 |
Xia L, Li X, Zhu J, Gao Z, Zhang J, Yang G, Wang Z. Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy. Radiat Oncol 2023;18:41. [PMID: 36829219 DOI: 10.1186/s13014-023-02224-5] [Reference Citation Analysis]
|
| 17 |
Xiao H, Bertwistle D, Khela K, Middleton-Dalby C, Hall J. Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment. BMC Cancer 2023;23:186. [PMID: 36823552 DOI: 10.1186/s12885-023-10553-7] [Reference Citation Analysis]
|
| 18 |
Zhang ZF. EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell Carcinoma. Med Sci Monit 2023;29:e938512. [PMID: 36852560 DOI: 10.12659/MSM.938512] [Reference Citation Analysis]
|
| 19 |
Cheng D, Zhao W, Chen R, Li D, Tang S, Fang C, Ji M. Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma. World J Surg Oncol 2023;21:33. [PMID: 36737768 DOI: 10.1186/s12957-023-02915-z] [Reference Citation Analysis]
|
| 20 |
Musbahi A, Rao CB, Immanuel A, Hayes N. Online patient literature related to oesophageal surgery: the need for greater readability, accreditation and higher quality. Ann R Coll Surg Engl 2023;105:107-12. [PMID: 35438572 DOI: 10.1308/rcsann.2021.0256] [Reference Citation Analysis]
|
| 21 |
Vosough P, Khatami SH, Hashemloo A, Tajbakhsh A, Karimi-Fard F, Taghvimi S, Taheri-Anganeh M, Soltani Fard E, Savardashtaki A, Movahedpour A. Exosomal lncRNAs in gastrointestinal cancer. Clin Chim Acta 2023;540:117216. [PMID: 36592922 DOI: 10.1016/j.cca.2022.117216] [Reference Citation Analysis]
|
| 22 |
Cai G, Li C, Li J, Yang J, Li C, Sun L, Li J, Yu J, Meng X. Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer. Int J Radiat Oncol Biol Phys 2023;115:366-81. [PMID: 35973623 DOI: 10.1016/j.ijrobp.2022.08.013] [Reference Citation Analysis]
|
| 23 |
Ma Y, Li W, Chen S, Lin S, Ding S, Zhou X, Liu T, Wang R, Wang W. Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. Int J Cancer 2023;152:436-46. [PMID: 36214796 DOI: 10.1002/ijc.34315] [Reference Citation Analysis]
|
| 24 |
He W, Yuan K, He J, Wang C, Peng L, Han Y, Chen N. Network and pathway-based analysis of genes associated with esophageal squamous cell carcinoma. Ann Transl Med 2023;11:102. [PMID: 36819552 DOI: 10.21037/atm-22-6512] [Reference Citation Analysis]
|
| 25 |
Yuan H, Qing T, Zhu S, Yang X, Wu W, Xu K, Chen H, Jiang Y, Zhu C, Yuan Z, Zhang T, Jin L, Suo C, Lu M, Chen X, Ye W. The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma. Cancer Med 2023. [PMID: 36708047 DOI: 10.1002/cam4.5663] [Reference Citation Analysis]
|
| 26 |
Liu MY, Wang CH, Lee SH, Chang WC, Wu CE, Liu HE. Effectiveness of a Protocol Intervention for Aspiration Pneumonia Prevention in Patients With Esophageal Cancer During Concurrent Chemoradiotherapy: A Randomized Control Trial. Cancer Nurs 2023. [PMID: 36696534 DOI: 10.1097/NCC.0000000000001205] [Reference Citation Analysis]
|
| 27 |
Thavanesan N, Vigneswaran G, Bodala I, Underwood TJ. The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making? J Gastrointest Surg 2023. [PMID: 36689150 DOI: 10.1007/s11605-022-05575-8] [Reference Citation Analysis]
|
| 28 |
Macedo-Silva C, Constâncio V, Miranda-Gonçalves V, Leite-Silva P, Salta S, Lobo J, Guimarães R, Carvalho-Maia C, Gigliano D, Farinha M, Sousa O, Henrique R, Jerónimo C. DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation. Cancer Med 2023. [PMID: 36670548 DOI: 10.1002/cam4.5623] [Reference Citation Analysis]
|
| 29 |
Yuan S, Wei C, Wang M, Deng W, Zhang C, Li N, Luo S. Prognostic impact of examined lymph-node count for patients with esophageal cancer: development and validation prediction model. Sci Rep 2023;13:476. [PMID: 36627338 DOI: 10.1038/s41598-022-27150-6] [Reference Citation Analysis]
|
| 30 |
Kitamura Y, Koma YI, Tanigawa K, Tsukamoto S, Azumi Y, Miyako S, Urakami S, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2023;15. [PMID: 36672342 DOI: 10.3390/cancers15020394] [Reference Citation Analysis]
|
| 31 |
Wang JL, Mu XY, Ma R, Bai XH, Zhao ZJ, Wang YY. Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK. J Oncol 2023;2023:2339732. [PMID: 36644234 DOI: 10.1155/2023/2339732] [Reference Citation Analysis]
|
| 32 |
Zhang XY, Lv QY, Zou CL. A nomogram model to individually predict prognosis for esophageal cancer with synchronous pulmonary metastasis. Front Oncol 2022;12:956738. [PMID: 36686804 DOI: 10.3389/fonc.2022.956738] [Reference Citation Analysis]
|
| 33 |
Zhang ZF. A novel pyroptosis scoring model was associated with the prognosis and immune microenvironment of esophageal squamous cell carcinoma. Front Genet 2022;13:1034606. [PMID: 36685978 DOI: 10.3389/fgene.2022.1034606] [Reference Citation Analysis]
|
| 34 |
Han J, Guo X, Zhao L, Zhang H, Ma S, Li Y, Zhao D, Wang J, Xue F. Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program. JAMA Netw Open 2023;6:e2253148. [PMID: 36701154 DOI: 10.1001/jamanetworkopen.2022.53148] [Reference Citation Analysis]
|
| 35 |
Testa U, Castelli G, Pelosi E. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. Curr Oncol 2023;30:610-40. [PMID: 36661697 DOI: 10.3390/curroncol30010048] [Reference Citation Analysis]
|
| 36 |
Ilhan-mutlu A. Dual immune checkpoint blockade in gastroesophageal tumors: never say never. memo 2023. [DOI: 10.1007/s12254-022-00870-1] [Reference Citation Analysis]
|
| 37 |
Meinikheim M, Messmann H, Ebigbo A. Role of artificial intelligence in diagnosing Barrett's esophagus-related neoplasia. Clin Endosc 2023;56:14-22. [PMID: 36646423 DOI: 10.5946/ce.2022.247] [Reference Citation Analysis]
|
| 38 |
van Hoeve JC, Verhoeven RHA, Nagengast WB, Oppedijk V, Lynch MG, van Rooijen JM, Veldhuis P, Siesling S, Kouwenhoven EA. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival. Eur J Surg Oncol 2023;49:106-12. [PMID: 35963750 DOI: 10.1016/j.ejso.2022.07.022] [Reference Citation Analysis]
|
| 39 |
Sharma U, Kaur Rana M, Singh K, Jain A. LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway. Biochem Pharmacol 2023;207:115372. [PMID: 36493845 DOI: 10.1016/j.bcp.2022.115372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Ooki A, Osumi H, Chin K, Watanabe M, Yamaguchi K. Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. Ther Adv Med Oncol 2023;15:17588359221138377. [PMID: 36872946 DOI: 10.1177/17588359221138377] [Reference Citation Analysis]
|
| 41 |
Yang W, Liu F, Xu R, Yang W, He Y, Liu Z, Zhou F, Heng F, Hou B, Zhang L, Chen L, Zhang F, Cai F, Xu H, Lin M, Liu M, Pan Y, Liu Y, Hu Z, Chen H, He Z, Ke Y. Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-World Data. Ann Surg 2023;277:e61-9. [PMID: 34091512 DOI: 10.1097/SLA.0000000000004958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 42 |
Luo H, Wang L, Zhang D, Sun Y, Wang S, Song S, Ge H. HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer Sci 2022. [PMID: 36582172 DOI: 10.1111/cas.15712] [Reference Citation Analysis]
|
| 43 |
Wu B, Li S, Zhai Y, Li Z, Li F, Dong B, Sheng Y, Huang L, Qi Y. Analysis of the crosstalk between EMT-related gene and Tumor-infiltrating immune cell in Esophageal Squamous Cell Carcinoma.. [DOI: 10.21203/rs.3.rs-2365658/v1] [Reference Citation Analysis]
|
| 44 |
Mei PY, Xiao H, Guo Q, Meng WY, Wang ML, Huang QF, Liao YD. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer. Oncol Lett 2023;25:68. [PMID: 36644145 DOI: 10.3892/ol.2022.13654] [Reference Citation Analysis]
|
| 45 |
Sugawara K, Fukuda T, Kishimoto Y, Oka D, Tanaka Y, Hara H, Yoshii T, Kawashima Y. The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients. Ann Surg Oncol 2022. [DOI: 10.1245/s10434-022-12945-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 46 |
Zhao WJ, Liu Y, Guo J, Liu H. Prognostic Biomarkers Identification in Esophageal Cancer Based on WGCNA and Single-Cell Analysis. Dis Markers 2022;2022:6595778. [PMID: 36569220 DOI: 10.1155/2022/6595778] [Reference Citation Analysis]
|
| 47 |
He F, Xiao H, Cai Y, Zhang N. NSD1 promotes esophageal cancer tumorigenesis via HIF1α signaling. Cell Biol Toxicol 2022. [DOI: 10.1007/s10565-022-09786-2] [Reference Citation Analysis]
|
| 48 |
Zhang Y, Chen X, Qiao Y, Yang S, Wang Z, Ji M, Yin K, Zhao J, Liu K, Yuan B. DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin β1 as a Molecular Target. Anal Chem 2022;94:17212-22. [PMID: 36459499 DOI: 10.1021/acs.analchem.2c03863] [Reference Citation Analysis]
|
| 49 |
Peng MY, Zuo ZG, Cao FJ, Yu YD, Cai XJ, Wan GX. Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma. Medicina (Kaunas) 2022;58. [PMID: 36557010 DOI: 10.3390/medicina58121808] [Reference Citation Analysis]
|
| 50 |
Shitara K, Kawazoe A, Hirakawa A, Nakanishi Y, Furuki S, Fukuda M, Ueno Y, Raizer J, Arozullah A. Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma. Cancer Sci 2022. [PMID: 36478334 DOI: 10.1111/cas.15684] [Reference Citation Analysis]
|
| 51 |
Huang B, Deng Y, Liu Z, Zhu X, Su Y, Gu D, Li Z, Fang W, Pennathur A, Luketich JD, Xiang J, Chen H, Wu Q, Xu W, Zhang J. Oesophagectomy following noncurative endoscopic resection for oesophageal carcinoma: does interval matter? Eur J Cardiothorac Surg 2022;63:ezac565. [PMID: 36594564 DOI: 10.1093/ejcts/ezac565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Shi Z, Zhu X, Ruan C, Wei G, Li J, Qiu H, Gao L, Cai G, Zhangcai Y, Li B, Wang J, Gong Y, Chen J, Zhao W, Wu Y, Ke S, Chen Y. Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma. JAMA Netw Open 2022;5:e2244619. [PMID: 36454568 DOI: 10.1001/jamanetworkopen.2022.44619] [Reference Citation Analysis]
|
| 53 |
Tankel J, Söderström H, Reizine E, Artho G, Calderone A, Mueller C, Najmeh S, Spicer J, Ferri L, Cools-Lartigue J. Change in Density Not Size of Esophageal Adenocarcinoma During Neoadjuvant Chemotherapy Is Associated with Improved Survival Outcomes. J Gastrointest Surg 2022;26:2417-25. [PMID: 36214951 DOI: 10.1007/s11605-022-05422-w] [Reference Citation Analysis]
|
| 54 |
Zheng KH, Kroon J, Schoormans J, Gurney-Champion O, Meijer SL, Gisbertz SS, Hulshof MCCM, Vugts DJ, van Dongen GAMS, Coolen BF, Verberne HJ, Nederveen AJ, Stroes ESG, van Laarhoven HWM. (89)Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer. J Nucl Med 2022;63:1880-6. [PMID: 35738904 DOI: 10.2967/jnumed.121.263330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 55 |
Shi C, Ma C, Ren C, Li N, Liu X, Zhang Y, Wang Y, Li X, Lv P, Han C, Li X. LINC00629, a KLF10-responsive lncRNA, promotes the anticancer effects of apigenin by decreasing Mcl1 stability in oral squamous cell carcinoma. Aging (Albany NY) 2022;14:9149-66. [PMID: 36445338 DOI: 10.18632/aging.204396] [Reference Citation Analysis]
|
| 56 |
Georgy SR, Rudiatmoko DR, Auden A, Partridge D, Butt T, Srivastava S, Wong N, Swaroop D, Carpinelli MR, Bogeski M, Jane SM. Identification of a Novel GRHL3/HOPX/Wnt/β-Catenin Proto-oncogenic Axis in Squamous Cell Carcinoma of the Esophagus. Cell Mol Gastroenterol Hepatol 2022;15:1051-69. [PMID: 36442813 DOI: 10.1016/j.jcmgh.2022.11.009] [Reference Citation Analysis]
|
| 57 |
Godefa TM, Derks S, Thijssen VLJL. Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives. Cancers (Basel) 2022;14. [PMID: 36497271 DOI: 10.3390/cancers14235790] [Reference Citation Analysis]
|
| 58 |
Sato H, Noma K, Ohara T, Kawasaki K, Akai M, Kobayashi T, Nishiwaki N, Narusaka T, Komoto S, Kashima H, Katsura Y, Kato T, Kikuchi S, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, Fujiwara T. Dual-targeted near-infrared photoimmunotherapy for esophageal cancer and cancer-associated fibroblasts in the tumor microenvironment. Sci Rep 2022;12:20152. [PMID: 36418422 DOI: 10.1038/s41598-022-24313-3] [Reference Citation Analysis]
|
| 59 |
Muszyński D, Kudra A, Sobocki BK, Folwarski M, Vitale E, Filetti V, Dudzic W, Kaźmierczak-siedlecka K, Połom K. Esophageal cancer and bacterial part of gut microbiota – A multidisciplinary point of view. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1057668] [Reference Citation Analysis]
|
| 60 |
Zhou J, Lin H, Xu X, Wang X, Rong L, Zhang Y, Shen L, Xu L, Qin W, Ye Q, Ma X, Bai Y. The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1041126] [Reference Citation Analysis]
|
| 61 |
Tokunaga Y, Otsuyama KI, Kakuta S, Hayashida N. Heat Shock Transcription Factor 2 Is Significantly Involved in Neurodegenerative Diseases, Inflammatory Bowel Disease, Cancer, Male Infertility, and Fetal Alcohol Spectrum Disorder: The Novel Mechanisms of Several Severe Diseases. Int J Mol Sci 2022;23. [PMID: 36430241 DOI: 10.3390/ijms232213763] [Reference Citation Analysis]
|
| 62 |
Wang D, Dai J, Suo C, Wang S, Zhang Y, Chen X. Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1033214] [Reference Citation Analysis]
|
| 63 |
Gao D, Ou J, Tan B, Yu Z, Li K, Li R, Zhang X, Chen T, Zhou H. A Novel Quantitative Model Based on Gross Tumor Volume Corresponding to Anatomical Distribution Measured with Multidetector Computed Tomography to Determine Resectability of Non-distant Metastatic Esophageal Squamous Cell Carcinoma: A Case Control Study.. [DOI: 10.21203/rs.3.rs-2115716/v1] [Reference Citation Analysis]
|
| 64 |
Zhang Q, Lin X, Jiang K, Deng J, Ke L, Wu Z, Xia P, Li Q, Yu L, Ni P, Lv W, Hu J. PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1061988] [Reference Citation Analysis]
|
| 65 |
Hesong Wang, Chunyang Song, Xiaohan Zhao, Wenzhao Deng, Wenbin Shen. The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis. Front Oncol 2022;12:1034656. [PMID: 36408184 DOI: 10.3389/fonc.2022.1034656] [Reference Citation Analysis]
|
| 66 |
Aisa A, Weng S, Li X, Zhang D, Yuan Y. Immune Checkpoint Inhibitors combined with HER-2 targeted therapy in HER-2 positive Gastroesophageal cancer. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103864] [Reference Citation Analysis]
|
| 67 |
Venkitachalam S, Babu D, Ravillah D, Katabathula RM, Joseph P, Singh S, Udhayakumar B, Miao Y, Martinez-Uribe O, Hogue JA, Kresak AM, Dawson D, LaFramboise T, Willis JE, Chak A, Garman KS, Blum AE, Varadan V, Guda K. The Ephrin B2 Receptor Tyrosine Kinase Is a Regulator of Proto-oncogene MYC and Molecular Programs Central to Barrett's Neoplasia. Gastroenterology 2022;163:1228-41. [PMID: 35870513 DOI: 10.1053/j.gastro.2022.07.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 68 |
Blum AE, Ravillah D, Katabathula RM, Khalighi S, Varadan V, Guda K; Betrnet Consortium. HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus. Gastroenterology 2022;163:1457-60. [PMID: 35934060 DOI: 10.1053/j.gastro.2022.07.073] [Reference Citation Analysis]
|
| 69 |
Dobashi A, Li DK, Mavrogenis G, Visrodia KH, Bazerbachi F. Endoscopic Management of Esophageal Cancer. Thoracic Surgery Clinics 2022;32:479-495. [DOI: 10.1016/j.thorsurg.2022.07.005] [Reference Citation Analysis]
|
| 70 |
Ma TL, Zhu P, Chen JX, Hu YH, Xie J. SIX3 function in cancer: progression and comprehensive analysis. Cancer Gene Ther 2022;29:1542-9. [PMID: 35764712 DOI: 10.1038/s41417-022-00488-9] [Reference Citation Analysis]
|
| 71 |
Dong R, Lu J, Zeng CH, Li H, Guo JH. Safety and Efficacy of Computed Tomography-Guided Iodine-125 Brachytherapy as a Salvage Treatment for Locoregional Lymph Node Recurrence of Esophageal Cancer. J Vasc Interv Radiol 2022;33:1399-407. [PMID: 35863631 DOI: 10.1016/j.jvir.2022.07.017] [Reference Citation Analysis]
|
| 72 |
Jajosky A, Fels Elliott DR. Esophageal Cancer Genetics and Clinical Translation. Thoracic Surgery Clinics 2022;32:425-435. [DOI: 10.1016/j.thorsurg.2022.06.002] [Reference Citation Analysis]
|
| 73 |
Augustin JE, Soussan P, Bass AJ. Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma. Ann Oncol 2022;33:1134-48. [PMID: 35963482 DOI: 10.1016/j.annonc.2022.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 74 |
Darbani Torshizi M, Younesian O, Aboomardani M, Roshandel G, Hosseinzadeh S, Hosseini Alarzi SS, Joshaghani H. Serum Selenium, Vitamin A, and Vitamin E Levels of Healthy Individuals in High‐ and Low‐Risk Areas of Esophageal Cancer. Middle East J Dig Dis 2022;14:396-403. [DOI: 10.34172/mejdd.2022.300] [Reference Citation Analysis]
|
| 75 |
Tian L, Huang Y, Zhang B, Song Y, Yang L, Chen Q, Wang Z, Wang Y, He Q, Yang W, Yu S, Lu T, Gao K, Fan X, Song J, Zhai R. LncRNA LLNLR-299G3.1 promotes ESCC progression by regulating cancer related genes through RNA-chromatin interactions.. [DOI: 10.21203/rs.3.rs-2181762/v1] [Reference Citation Analysis]
|
| 76 |
Peng G, Zhan Y, Wu Y, Zeng C, Wang S, Guo L, Liu W, Luo L, Wang R, Huang K, Huang B, Chen J, Chen C. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089). Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.988859] [Reference Citation Analysis]
|
| 77 |
Tang CL, Tsai WC, Lee JY, Wang YK, Chen YH, Liu YW, Lin MC, Fang PT, Huang YL, Wu IC. Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes. BMC Cancer 2022;22:1086. [PMID: 36271384 DOI: 10.1186/s12885-022-10180-8] [Reference Citation Analysis]
|
| 78 |
Sun D, Xu J, Zhang W, Song C, Gao C, He Y, Shang Y. Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases. Front Immunol 2022;13:1012459. [DOI: 10.3389/fimmu.2022.1012459] [Reference Citation Analysis]
|
| 79 |
Wang N, Pei B, Yuan X, Yi C, Wiredu Ocansey DK, Qian H, Mao F. Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers. Front Bioeng Biotechnol 2022;10:1019459. [DOI: 10.3389/fbioe.2022.1019459] [Reference Citation Analysis]
|
| 80 |
Harada K, Yamamoto S, Kato K. Pembrolizumab: first anti-PD-1/L1-based regimen for first-line treatment of advanced esophageal cancer in Japan. Expert Opin Biol Ther 2022;:1-6. [PMID: 36266954 DOI: 10.1080/14712598.2022.2138327] [Reference Citation Analysis]
|
| 81 |
Chen H, Sun G, Han Z, Wang H, Li J, Ye H, Song C, Zhang J, Wang P. Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma. Medicina (Kaunas) 2022;58:1480. [PMID: 36295640 DOI: 10.3390/medicina58101480] [Reference Citation Analysis]
|
| 82 |
Zhang S, Liu S, Ren J, Zhang H, Chen S, Chen Y, Zhang S, Chen W, Xu C, Zhong S, Liu S, Lin C. Tumor-derived extracellular vesicles confer 5-fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery. Mol Carcinog 2022. [PMID: 36239547 DOI: 10.1002/mc.23469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 83 |
Cheng D, Zhao W, Chen R, Li D, Tang S, Fang C, Ji M. Neoadjuvant PD-1 blockade combined with chemotherapy or chemotherapy alone for patients with resectable locally advanced esophageal carcinoma: A real-world data analysis.. [DOI: 10.21203/rs.3.rs-2114958/v1] [Reference Citation Analysis]
|
| 84 |
Rong Y, Hao Y, Xue J, Li X, Li Q, Wang L, Li T. Comparison of complications and long-term survival after minimally invasive esophagectomy versus open esophagectomy in patients with esophageal cancer and chronic obstructive pulmonary disease. Front Oncol 2022;12:934950. [DOI: 10.3389/fonc.2022.934950] [Reference Citation Analysis]
|
| 85 |
Zhou B, Bie F, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Huai Q, Li Y, Zhao L, Gao S. Global burden and temporal trends in incidence and mortality of oesophageal cancer. Journal of Advanced Research 2022. [DOI: 10.1016/j.jare.2022.10.007] [Reference Citation Analysis]
|
| 86 |
Li C, Ma YQ. Prognostic significance of sex determining region Y-box 2, E-cadherin, and vimentin in esophageal squamous cell carcinoma. World J Clin Cases 2022; 10(27): 9657-9669 [DOI: 10.12998/wjcc.v10.i27.9657] [Reference Citation Analysis]
|
| 87 |
Mbatha S, Hull R, Dlamini Z. Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. Biomedicines 2022;10:2359. [DOI: 10.3390/biomedicines10102359] [Reference Citation Analysis]
|
| 88 |
Hayes M, Gillman A, Wright B, Dorgan S, Brennan I, Walshe M, Donohoe C, Reynolds JV, Regan J. Prevalence, nature and trajectory of dysphagia postoesophageal cancer surgery: a prospective longitudinal study protocol. BMJ Open 2022;12:e058815. [PMID: 36137623 DOI: 10.1136/bmjopen-2021-058815] [Reference Citation Analysis]
|
| 89 |
Xu X, Sun Z, Rong L, Wang X, Xu L, Lu J, Ye Q, Zhang L, Bai Y, Ma X. Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy. Front Genet 2022;13:988433. [DOI: 10.3389/fgene.2022.988433] [Reference Citation Analysis]
|
| 90 |
Gao T, Shan J, Yang Y, Zhang Z, Liu S, Xi M, Liu M, Zhao L. Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-10086-5] [Reference Citation Analysis]
|
| 91 |
Yang J, Zhang X, Yang G, Mi X, Zhang Y, Sui Y, Yuchi A. Study on the Application Value of Concurrent Chemoradiotherapy and Clinical Nursing Pathway for Postoperative Patients with Esophageal Cancer. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/2216529] [Reference Citation Analysis]
|
| 92 |
Wang S, Liang Y, Zhang J, Wang W, Hong Y, Sun M, Shu J, Chen K. The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification. Front Oncol 2022;12:961634. [DOI: 10.3389/fonc.2022.961634] [Reference Citation Analysis]
|
| 93 |
Liu J, Shen H, Chen X, Ding Y, Wang H, Xu N, Teng L. Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer. Genes (Basel) 2022;13:1582. [PMID: 36140750 DOI: 10.3390/genes13091582] [Reference Citation Analysis]
|
| 94 |
Fan Y, Li X, Sun H, Gao Z, Zhu Z, Yuan K. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential. Biomolecules 2022;12:1224. [PMID: 36139062 DOI: 10.3390/biom12091224] [Reference Citation Analysis]
|
| 95 |
Zhou P, Wang R, Yu H, Zhang Y, Zhang G, Zhang S. Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer. Front Oncol 2022;12:898141. [DOI: 10.3389/fonc.2022.898141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 96 |
Tang C, Tsai W, Lee J, Wang Y, Chen Y, Liu Y, Lin M, Fang P, Huang Y, Wu I. Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes.. [DOI: 10.21203/rs.3.rs-1931144/v1] [Reference Citation Analysis]
|
| 97 |
Davern M, Donlon NE, Sheppard AS, Majcher KD, Connell FO, Heeran AB, Grant M, Farrell RA, Hayes C, Bracken-clarke D, Conroy MJ, Foley E, Toole DO, Bhardwaj A, Ravi N, Reynolds JV, Maher SG, Sullivan JO, Lysaght J. FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-04283-9] [Reference Citation Analysis]
|
| 98 |
Li Y, Dong L, Xue L, Fang C, Cheng W, Tang J. Survival analysis of patients with oral squamous cell carcinoma treated by radical surgery for the first time.. [DOI: 10.21203/rs.3.rs-1869209/v1] [Reference Citation Analysis]
|
| 99 |
Zhang Z, Leng Z, Fang K, Sun M, Li Z, Kang L, Chen T, Xu M. Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis. Front Oncol 2022;12:977935. [DOI: 10.3389/fonc.2022.977935] [Reference Citation Analysis]
|
| 100 |
Xu J, Bai Y, Li E, Xu N, Shi D, Qian J. Efficacy and safety of chemotherapy regimens for first-line treatment of advanced esophageal squamous cell carcinoma in asia: a systematic review. Expert Rev Anticancer Ther 2022. [PMID: 35950848 DOI: 10.1080/14737140.2022.2110470] [Reference Citation Analysis]
|
| 101 |
Wang Y, Li K, Xie X, Bao T, Hao Z, Long J, Wang S, Zhong Z, Guo W. Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial. Front Oncol 2022;12:908841. [DOI: 10.3389/fonc.2022.908841] [Reference Citation Analysis]
|
| 102 |
Chidambaram S, Patel NM, Sounderajah V, Alfieri R, Bonavina L, Cheong E, Cockbain A, D'Journo XB, Ferri L, Griffiths EA, Grimminger P, Gronnier C, Gutschow C, Hedberg J, Kauppila JH, Lagarde S, Low D, Nafteux P, Nieuwenhuijzen G, Nilsson M, Rosati R, Schroeder W, Smithers BM, van Berge Henegouwen MI, van Hillegesberg R, Watson DI, Vohra R, Maynard N, Markar SR. Identifying a core symptom set triggering radiological and endoscopic investigations for suspected recurrent esophago-gastric cancer: a modified Delphi consensus process. Dis Esophagus 2022;36. [PMID: 35858213 DOI: 10.1093/dote/doac038] [Reference Citation Analysis]
|
| 103 |
Hao WW, Xu F. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. World J Gastrointest Oncol 2022; 14(7): 1239-1251 [DOI: 10.4251/wjgo.v14.i7.1239] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 104 |
Yang B, Zhang X, Zhou H, Zhang X, Yang W, Lu J, Guo Z, Dong Z, Wu Q, Tian F. Preliminary study on the role and mechanism of KIRREL3 in the development of esophageal squamous cell carcinoma. Pathol Res Pract 2022;237:154025. [PMID: 35863131 DOI: 10.1016/j.prp.2022.154025] [Reference Citation Analysis]
|
| 105 |
O’dowd D, O’sullivan J, Marcone S. Prognostic, Diagnostic and Predictive Biomarkers in the Barrett’s Oesophagus-Adenocarcinoma Disease Sequence. Cancers 2022;14:3427. [DOI: 10.3390/cancers14143427] [Reference Citation Analysis]
|
| 106 |
Zhao F, Dong Z, Li Y, Liu S, Guo P, Zhang D, Li S. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma. Front Oncol 2022;12:893186. [DOI: 10.3389/fonc.2022.893186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 107 |
Huibertse LJ, Peters Y, Westendorp D, Siersema PD. Unsedated transnasal endoscopy for the detection of Barrett's esophagus: systematic review and meta-analysis. Dis Esophagus 2023;36. [PMID: 35830873 DOI: 10.1093/dote/doac045] [Reference Citation Analysis]
|
| 108 |
Abula G, Song WX, Liu H, Ren XF, Chen X. Prediction model for selection of adjuvant therapy population after endoscopic submucosal dissection for early esophageal lesions. Shijie Huaren Xiaohua Zazhi 2022; 30(13): 587-598 [DOI: 10.11569/wcjd.v30.i13.587] [Reference Citation Analysis]
|
| 109 |
Sui Z, Wu X, Du L, Wang H, Yuan L, Zhang JV, Yu Z. Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma. Front Oncol 2022;12:879326. [DOI: 10.3389/fonc.2022.879326] [Reference Citation Analysis]
|
| 110 |
Moore J, Hekman R, Blum BC, Lawton M, Lehoux S, Stachler M, Pleskow D, Sawhney MS, Cummings RD, Emili A, Qureshi A. Pilot Study Showing Feasibility of Phosphoproteomic Profiling of Pathway-Level Molecular Alterations in Barrett’s Esophagus. Genes 2022;13:1215. [DOI: 10.3390/genes13071215] [Reference Citation Analysis]
|
| 111 |
Xu C, Lin S, Lu Y, Mao L, Li S, Li Z. C12orf59 Promotes Esophageal Squamous Cell Carcinoma Progression via YAP-Mediated Epithelial-Mesenchymal Transition. Front Oncol 2022;12:927249. [DOI: 10.3389/fonc.2022.927249] [Reference Citation Analysis]
|
| 112 |
Januszewicz W, Witczak K, Wieszczy P, Socha M, Turkot MH, Wojciechowska U, Didkowska J, Kaminski MF, Regula J. Prevalence and risk factors of upper gastrointestinal cancers missed during endoscopy: a nationwide registry-based study. Endoscopy 2022;54:653-60. [PMID: 34674210 DOI: 10.1055/a-1675-4136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 113 |
Sawas T, Katzka DA. Esophageal adenocarcinoma phenotypes and risk factors. Curr Opin Gastroenterol 2022;38:423-7. [PMID: 35762703 DOI: 10.1097/MOG.0000000000000844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Wu S, Yin X, Xia N, Zhang P, Liu B, Weng L, Shang M. GPX2 stabilized by PCBP2 induces autophagy to protect Het-1A esophageal cells from apoptosis and inflammation. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110397] [Reference Citation Analysis]
|
| 115 |
Pan J, Zang Y. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis. Dig Dis Sci 2022;67:2936-47. [PMID: 34313922 DOI: 10.1007/s10620-021-07145-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 116 |
Soroush A, Etemadi A, Abrams JA. Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2022;67:2754-62. [PMID: 34236559 DOI: 10.1007/s10620-021-07127-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 117 |
Ma X, Zhao W, Li B, Yu Y, Ma Y, Thomas M, Zhang Y, Xiang J, Zhang Y. Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes. Front Oncol 2022;12:810898. [PMID: 35756623 DOI: 10.3389/fonc.2022.810898] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 118 |
Zhao X, Wang Y, Meng F, Liu Z, Xu B. Risk Stratification and Validation of Eleven Autophagy-Related lncRNAs for Esophageal Squamous Cell Carcinoma. Front Genet 2022;13:894990. [DOI: 10.3389/fgene.2022.894990] [Reference Citation Analysis]
|
| 119 |
Zhang P, She Y, Gao J, Feng Z, Tan Q, Min X, Xu S. Development of a Deep Learning System to Detect Esophageal Cancer by Barium Esophagram. Front Oncol 2022;12:766243. [DOI: 10.3389/fonc.2022.766243] [Reference Citation Analysis]
|
| 120 |
Udhaya Kumar S, Balasundaram A, Anu Preethi V, Chatterjee S, Kameshwari Gollakota GV, Kashyap MK, George Priya Doss C, Zayed H. Integrative ontology and pathway-based approach identifies distinct molecular signatures in transcriptomes of esophageal squamous cell carcinoma. Adv Protein Chem Struct Biol 2022;131:177-206. [PMID: 35871890 DOI: 10.1016/bs.apcsb.2022.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 121 |
Pan Z, Zheng Z, Ye W, Chen C, Ye S. Overexpression of GNA13 correlates with poor prognosis in esophageal squamous cell carcinoma after esophagectomy. Int J Biol Markers 2022;:3936155221106799. [PMID: 35706395 DOI: 10.1177/03936155221106799] [Reference Citation Analysis]
|
| 122 |
Pinto R, Hauge T, Jeanmougin M, Pharo HD, Kresse SH, Honne H, Winge SB, Five MB, Kumar T, Mala T, Hauge T, Johnson E, Lind GE. Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus. Clin Epigenetics 2022;14:77. [PMID: 35701814 DOI: 10.1186/s13148-022-01287-7] [Reference Citation Analysis]
|
| 123 |
Zhou Y, Li X, Luo W, Zhu J, Zhao J, Wang M, Sang L, Chang B, Wang B. Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment. Front Pharmacol 2022;13:903259. [DOI: 10.3389/fphar.2022.903259] [Reference Citation Analysis]
|
| 124 |
Donlon NE, Davern M, O’Connell F, Sheppard A, Heeran A, Bhardwaj A, Butler C, Narayanasamy R, Donohoe C, Phelan JJ, Lynam-Lennon N, Dunne MR, Maher S, O’Sullivan J, Reynolds JV, Lysaght J. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma. World J Gastroenterol 2022; 28(21): 2302-2319 [DOI: 10.3748/wjg.v28.i21.2302] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Lu T, Xu R, Wang C, Zhao J, Peng B, Wang J, Zhang L. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Front Genet 2022;13:853113. [DOI: 10.3389/fgene.2022.853113] [Reference Citation Analysis]
|
| 126 |
Fang Y, Yin J, Shen Y, Wang H, Tang H, Chen X. CircCDR1 sponges miR-1290 to regulate cell proliferation, migration, invasion, and apoptosis in esophageal squamous cell cancer. Cell Cycle 2022;21:1316-34. [PMID: 35289243 DOI: 10.1080/15384101.2022.2050645] [Reference Citation Analysis]
|
| 127 |
Moballegh Nasery M, Varzandeh M, Pahlavanneshan S, Mohamadi N, Sarhadi S, Samareh Fekri H, Mohammadinejad R, Ahn KS. Curcumin: A potential therapeutic natural product for adenocarcinomas. Phytochemistry Letters 2022;49:45-55. [DOI: 10.1016/j.phytol.2022.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 128 |
Dean J, Goldberg E, Michor F. Designing optimal allocations for cancer screening using queuing network models. PLoS Comput Biol 2022;18:e1010179. [DOI: 10.1371/journal.pcbi.1010179] [Reference Citation Analysis]
|
| 129 |
Li Q, Zhang Z, Jiang H, Hou J, Chai Y, Nan H, Li F, Wang L. DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma. J Transl Med 2022;20:245. [PMID: 35619131 DOI: 10.1186/s12967-022-03449-w] [Reference Citation Analysis]
|
| 130 |
Liu W, Wang Q, Chang J, Bhetuwal A, Bhattarai N, Zhang F, Tang J. Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. Clin Proteomics 2022;19:18. [PMID: 35610567 DOI: 10.1186/s12014-022-09357-x] [Reference Citation Analysis]
|
| 131 |
Cui Y, Zhang S, Hu X, Gao F. Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling. Bioengineered 2022;13:12462-74. [PMID: 35587143 DOI: 10.1080/21655979.2022.2076008] [Reference Citation Analysis]
|
| 132 |
Wang M, Sun X, Xin H, Wen Z, Cheng Y. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma. Cancer Med 2022;11:4526-43. [PMID: 35593388 DOI: 10.1002/cam4.4840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 133 |
Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N7-methylguanosine (m7G) in cancer. J Hematol Oncol 2022;15:63. [PMID: 35590385 DOI: 10.1186/s13045-022-01285-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 134 |
Zhou Y, Guo S, Li Y, Chen F, Wu Y, Xiao Y, An J. METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker. Front Oncol 2022;12:824190. [PMID: 35574315 DOI: 10.3389/fonc.2022.824190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 135 |
Ling C, Zhou X, Gao Y, Sui X. Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response. Pharmaceuticals 2022;15:605. [DOI: 10.3390/ph15050605] [Reference Citation Analysis]
|
| 136 |
Zhao F, Li Y, Dong Z, Zhang D, Guo P, Li Z, Li S. Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2022;10:845293. [DOI: 10.3389/fcell.2022.845293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 137 |
Liang J, Wang Y, Cai L, Liu J, Yan J, Chen X, Wu X, Chen Q. Comparative Genomic Analysis Reveals Genetic Variations in Multiple Primary Esophageal Squamous Cell Carcinoma of Chinese Population. Front Oncol 2022;12:868301. [PMID: 35515115 DOI: 10.3389/fonc.2022.868301] [Reference Citation Analysis]
|
| 138 |
Weidle UH, Sela T, Brinkmann U, Niewoehner J. Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma. Cancer Genomics Proteomics 2022;19:283-98. [PMID: 35430563 DOI: 10.21873/cgp.20320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 139 |
Al-Kaabi A, Baranov NS, van der Post RS, Schoon EJ, Rosman C, van Laarhoven HWM, Verheij M, Verhoeven RHA, Siersema PD. Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study. Acta Oncol 2022;61:545-52. [PMID: 35112634 DOI: 10.1080/0284186X.2021.2024878] [Reference Citation Analysis]
|
| 140 |
Liu Y, Beeraka NM, Liu J, Chen K, Song B, Song Z, Luo J, Liu Y, Zheng A, Cui Y, Wang Y, Jia Z, Song X, Wang X, Wang H, Qi X, Ren J, Wu L, Cai J, Fang X, Wang X, Sinelnikov MY, Nikolenko VN, Greeshma MV, Fan R. Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial. BMJ Open 2022;12:e055273. [PMID: 35470188 DOI: 10.1136/bmjopen-2021-055273] [Reference Citation Analysis]
|
| 141 |
Liu S, Li X, Liu D, Xie S, Zhang S, Li Y, Xie Z. LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis. Front Oncol 2022;12:884448. [DOI: 10.3389/fonc.2022.884448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 142 |
Shou Y, Wang X, Chen C, Liang Y, Yang C, Xiao Q, Li H, Wang S, Shu J, Tian X, Chen K. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway. Cancer Cell Int 2022;22:153. [PMID: 35436935 DOI: 10.1186/s12935-022-02570-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 143 |
Qin J, Li Y, Li Z, Qin X, Zhou X, Zhang H, Li S. LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1. Clin Epigenetics 2022;14:51. [PMID: 35414117 DOI: 10.1186/s13148-022-01258-y] [Reference Citation Analysis]
|
| 144 |
Pinto E, Fabbian A, Alfieri R, Da Roit A, Marano S, Mattara G, Pilati P, Castoro C, Cavarzan M, Dalla Riva MS, Orrù L, Turchi GP. Critical Competences for the Management of Post-Operative Course in Patients with Digestive Tract Cancer: The Contribution of MADIT Methodology for a Nine-Month Longitudinal Study. Behav Sci (Basel) 2022;12. [PMID: 35447673 DOI: 10.3390/bs12040101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 145 |
Xian Q, Zhu D, Zheng D. The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/5871188] [Reference Citation Analysis]
|
| 146 |
Xie Y, Fu R, Xiao Z, Li G. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer. Pathol Oncol Res 2022;28:1610030. [PMID: 35356506 DOI: 10.3389/pore.2022.1610030] [Reference Citation Analysis]
|
| 147 |
Korbut E, Krukowska K, Magierowski M. Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models. Int J Mol Sci 2022;23:3312. [PMID: 35328735 DOI: 10.3390/ijms23063312] [Reference Citation Analysis]
|
| 148 |
Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R, Sun K, Guo S, Huang B, Liang Y, Wang L, Chen S, Wang Z, Wei W, Huang Y, Peng H, Jiang YZ, Choe J, Lin S. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat Commun 2022;13:1478. [PMID: 35304469 DOI: 10.1038/s41467-022-29125-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 149 |
Katz-Summercorn AC, Jammula S, Frangou A, Peneva I, O'Donovan M, Tripathi M, Malhotra S, di Pietro M, Abbas S, Devonshire G, Januszewicz W, Blasko A, Nowicki-Osuch K, MacRae S, Northrop A, Redmond AM, Wedge DC, Fitzgerald RC. Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity. Nat Commun 2022;13:1407. [PMID: 35301290 DOI: 10.1038/s41467-022-28237-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 150 |
Ignatova EO, Kozlov E, Ivanov M, Mileyko V, Menshikova S, Sun H, Fedyanin M, Tryakin A, Stilidi I. Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. World J Gastrointest Oncol 2022; 14(3): 628-645 [DOI: 10.4251/wjgo.v14.i3.628] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 151 |
Mei LX, Mo JX, Chen Y, Dai L, Wang YY, Chen MW. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2022;35:doab049. [PMID: 34318324 DOI: 10.1093/dote/doab049] [Reference Citation Analysis]
|
| 152 |
Zhao F, Gao S, Qin X, Niu R, Li Z, Wang C, Li S. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2022;10:820870. [DOI: 10.3389/fcell.2022.820870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 153 |
Xie C, Chen Z, Xu J, Meng Z, Huang Z, Lin J. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study. PeerJ 2022;10:e12974. [PMID: 35256918 DOI: 10.7717/peerj.12974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 154 |
Bonazzi V, Aoude L, Brosda S, Lonie J, Patel K, Bradford J, Koufariotis L, Wood S, Smithers BM, Waddell N, Barbour A. ctDNA as a biomarker of progression in oesophageal adenocarcinoma. ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 155 |
Cui Y, Yan M, Wu W, Lv P, Wang J, Huo Y, Lou Y, Ma X, Chang J, Guan F, Cao W. ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma. NPJ Precis Oncol 2022;6:12. [PMID: 35233069 DOI: 10.1038/s41698-022-00255-x] [Reference Citation Analysis]
|
| 156 |
Ringborg C, Johar A, Lagergren P. Health-related quality of life among family caregivers of oesophageal cancer survivors one year after curative intended treatment - a nationwide population-based study. Acta Oncol 2022;61:378-84. [PMID: 35000544 DOI: 10.1080/0284186X.2021.2023757] [Reference Citation Analysis]
|
| 157 |
Lang CCJ, Lloyd M, Alyacoubi S, Rahman S, Pickering O, Underwood T, Breininger SP. The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer. Cancers (Basel) 2022;14:1171. [PMID: 35267476 DOI: 10.3390/cancers14051171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 158 |
Chen J, Zhou Z, Lin X, Liao J, Zhang Y, Xie B, Huang Y, Peng L. Environmental Cadmium Exposure Promotes the Development, Progression and Chemoradioresistance of Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2022;10:792933. [DOI: 10.3389/fcell.2022.792933] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 159 |
Jiang W, de Jong JM, van Hillegersberg R, Read M. Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma. Cancers 2022;14:996. [DOI: 10.3390/cancers14040996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 160 |
Lohan-Codeço M, Barambo-Wagner ML, Nasciutti LE, Ribeiro Pinto LF, Meireles Da Costa N, Palumbo A Jr. Molecular mechanisms associated with chemoresistance in esophageal cancer. Cell Mol Life Sci 2022;79:116. [PMID: 35113247 DOI: 10.1007/s00018-022-04131-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 161 |
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. N Engl J Med 2022;386:449-62. [PMID: 35108470 DOI: 10.1056/NEJMoa2111380] [Cited by in Crossref: 165] [Cited by in F6Publishing: 90] [Article Influence: 165.0] [Reference Citation Analysis]
|
| 162 |
Bao Z, Li A, Lu X, Wang Z, Yu Y, Wu W, Zhao L, Li B, Wu X, Laster KV, Zhang C, Jiang Y, Dong Z, Liu K. Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell Death Dis 2022;13:189. [DOI: 10.1038/s41419-022-04642-x] [Reference Citation Analysis]
|
| 163 |
Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2022;19:95-111. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 164 |
Pan F, Wang K, Zheng M, Ren Y, Hao W, Yan J, Wang J. A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/8757656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 165 |
Cai A, Hu Y, Zhou Z, Qi Q, Wu Y, Dong P, Chen L, Wang F. PIWI-Interacting RNAs (piRNAs): Promising Applications as Emerging Biomarkers for Digestive System Cancer. Front Mol Biosci 2022;9:848105. [DOI: 10.3389/fmolb.2022.848105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 166 |
Küsters N, Grupp K, Grass JK, Bachmann K, Ghadban T, Uzunoglu FG, Tachezy M, Perez D, Reeh M, Izbicki JR, Melling N. CD147 expression lacks prognostic relevance in esophageal cancer. J Cancer Res Clin Oncol 2022. [PMID: 34997863 DOI: 10.1007/s00432-022-03917-2] [Reference Citation Analysis]
|
| 167 |
Tan PO, Soh AYS, Kusano C, Lee YY, Gotoda T. Is There an Increasing Incidence of Gastroesophageal Junctional Adenocarcinoma and Barrett Esophagus in Asia? A Review of Diagnostic Conundrums. Digestion 2022;103:37-44. [PMID: 34781299 DOI: 10.1159/000519922] [Reference Citation Analysis]
|
| 168 |
Zhang D, Yin H, Bauer TL, Rogers MP, Velotta JB, Morgan CT, Du W, Xu P, Qian X. Development of a novel miR-3648-related gene signature as a prognostic biomarker in esophageal adenocarcinoma. Ann Transl Med 2021;9:1702. [PMID: 34988211 DOI: 10.21037/atm-21-6237] [Reference Citation Analysis]
|
| 169 |
Rastogi A, Bihari C, Patil AG, Majumdar K, Das P. Molecular Classifications of Gastrointestinal Tract Tumors. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_23] [Reference Citation Analysis]
|
| 170 |
Fangchao Zhao, Zhirong Li, Zefang Dong, Zengying Wang, Pengfei Guo, Dengfeng Zhang, Shujun Li. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Front Immunol 2022;13:918154. [PMID: 35880180 DOI: 10.3389/fimmu.2022.918154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 171 |
Wen P, Dayyani F, Tao R, Zhong X. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry. Ann Transl Med 2022;10:70. [PMID: 35282073 DOI: 10.21037/atm-21-6589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Zhao M, Jin X, Chen Z, Zhang H, Zhan C, Wang H, Wang Q. Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat 2022;21:15330338221117003. [PMID: 35899307 DOI: 10.1177/15330338221117003] [Reference Citation Analysis]
|
| 173 |
Qiu L, Yang T, Hong Y, Huang X, Ma F, Pan Y, Li C, Zhong J. Pre- and Post-Surgical Health-Related Quality of Life Evaluation of Esophageal Carcinoma Patients. JCT 2022;13:585-597. [DOI: 10.4236/jct.2022.139051] [Reference Citation Analysis]
|
| 174 |
Zhu L, Yang F, Li X, Li Q, Zhong C. Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma. Front Genet 2021;12:743133. [PMID: 34956314 DOI: 10.3389/fgene.2021.743133] [Reference Citation Analysis]
|
| 175 |
Huang Z, Jin Y, Cai X, Chen L, Shen X, Li B, Chen H, Li Y. Association of the programmed death ligand‐1 combined positive score in tumors and clinicopathological features in esophageal cancer. Thoracic Cancer. [DOI: 10.1111/1759-7714.14285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 176 |
Gallerani G, Rossi T, Valgiusti M, Angeli D, Fici P, De Fanti S, Bandini E, Cocchi C, Frassineti GL, Bonafè M, Fabbri F. CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways. Cancers (Basel) 2021;13:6369. [PMID: 34944989 DOI: 10.3390/cancers13246369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 177 |
Zheng B, Ko KP, Fang X, Wang X, Zhang J, Jun S, Kim BJ, Luo W, Kim MJ, Jung YS, Cervantes CL, Park JI. A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia. iScience 2021;24:103440. [PMID: 34877497 DOI: 10.1016/j.isci.2021.103440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 178 |
Liu P, Wang GF, Peng H, Zhang L, Li XY, Zeng QM, Li Q, Zhou JH. Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis. Front Oncol 2021;11:621917. [PMID: 34912696 DOI: 10.3389/fonc.2021.621917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 179 |
Cutliffe AL, Mckenna SL, Chandrashekar DS, Ng A, Devonshire G, Fitzgerald RC, O’donovan TR, Mackrill JJ. Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma. Exploration of Targeted Anti-tumor Therapy 2021;2. [DOI: 10.37349/etat.2021.00063] [Reference Citation Analysis]
|
| 180 |
Zhu YG, Xiao BF, Zhang JT, Cui XR, Lu ZM, Wu N. Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application. Front Oncol 2021;11:763806. [PMID: 34858843 DOI: 10.3389/fonc.2021.763806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 181 |
Wang XY, Maswikiti EP, Zhu JY, Ma YL, Zheng P, Yu Y, Wang BF, Gao L, Chen H. Photodynamic therapy combined with immunotherapy for an advanced esophageal cancer with an obstruction post metal stent implantation: A case report and literature review. Photodiagnosis Photodyn Ther 2021;37:102671. [PMID: 34864195 DOI: 10.1016/j.pdpdt.2021.102671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 182 |
Fan X, Song J, Fan Y, Li J, Chen Y, Zhu H, Zhang Z. CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer. Int J Gen Med 2021;14:8689-710. [PMID: 34849012 DOI: 10.2147/IJGM.S338284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 183 |
Li J, Sang M, Zheng Y, Meng L, Gu L, Li Z, Liu F, Wu Y, Li W, Shan B. HNRNPUL1 inhibits cisplatin sensitivity of esophageal squamous cell carcinoma through regulating the formation of circMAN1A2. Exp Cell Res 2021;409:112891. [PMID: 34688610 DOI: 10.1016/j.yexcr.2021.112891] [Reference Citation Analysis]
|
| 184 |
Kato K, Ito Y, Nozaki I, Daiko H, Kojima T, Yano M, Ueno M, Nakagawa S, Takagi M, Tsunoda S, Abe T, Nakamura T, Okada M, Toh Y, Shibuya Y, Yamamoto S, Katayama H, Nakamura K, Kitagawa Y; Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology 2021;161:1878-1886.e2. [PMID: 34389340 DOI: 10.1053/j.gastro.2021.08.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 185 |
Kanamori J, Watanabe M, Maruyama S, Kanie Y, Fujiwara D, Sakamoto K, Okamura A, Imamura Y. Current status of robot-assisted minimally invasive esophagectomy: what is the real benefit? Surg Today 2021. [PMID: 34853881 DOI: 10.1007/s00595-021-02432-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 186 |
Nan H, Zhou L, Liang W, Meng J, Lin K, Li M, Hou J, Wang L. Epigenetically associated CCL20 upregulation correlates with esophageal cancer progression and immune disorder. Pathol Res Pract 2021;228:153683. [PMID: 34798484 DOI: 10.1016/j.prp.2021.153683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 187 |
Cao K, Ma T, Ling X, Liu M, Jiang X, Ma K, Zhu J, Ma J. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer. Ann Transl Med 2021;9:1591. [PMID: 34790797 DOI: 10.21037/atm-21-5217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 188 |
Didamson OC, Abrahamse H. Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine. Pharmaceutics 2021;13:1943. [PMID: 34834358 DOI: 10.3390/pharmaceutics13111943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 189 |
Sun Z, Ji N, Zhao R, Liang J, Jiang J, Tian H. Extrachromosomal circular DNAs are common and functional in esophageal squamous cell carcinoma. Ann Transl Med 2021;9:1464. [PMID: 34734016 DOI: 10.21037/atm-21-4372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 190 |
Zhou J, Sun S, Luan S, Xiao X, Yang Y, Mao C, Chen L, Zeng X, Zhang Y, Yuan Y. Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications. Front Oncol 2021;11:717242. [PMID: 34733778 DOI: 10.3389/fonc.2021.717242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 191 |
Sharma A, Khan H, Singh TG, Grewal AK, Najda A, Kawecka-Radomska M, Kamel M, Altyar AE, Del-Daim MM. Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling. Int J Mol Sci 2021;22:11971. [PMID: 34769401 DOI: 10.3390/ijms222111971] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 192 |
Adenis A, Kulkarni AS, Girotto GC, de la Fouchardiere C, Senellart H, van Laarhoven HWM, Mansoor W, Al-Rajabi R, Norquist J, Amonkar M, Suryawanshi S, Bhagia P, Metges JP. Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181. J Clin Oncol 2021;:JCO2100601. [PMID: 34730989 DOI: 10.1200/JCO.21.00601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 193 |
Strikanova I, Gumeneckaja J, Dzhabrailova S, Makarova K, Kireeva T. Clinical Case of Treatment of Stage IV Esophageal Cancer. Medical Radiology and radiation safety 2021;66:101-104. [DOI: 10.12737/1024-6177-2021-66-5-101-104] [Reference Citation Analysis]
|
| 194 |
Yang M, Hu P, Li M, Ding R, Wang Y, Pan S, Kang M, Kong W, Du D, Wang F. Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:722961. [PMID: 34722265 DOI: 10.3389/fonc.2021.722961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 195 |
Ji Q, Cai Y, Shrestha SM, Shen D, Zhao W, Shi R. Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma. Biomed Res Int 2021;2021:7430315. [PMID: 34722771 DOI: 10.1155/2021/7430315] [Reference Citation Analysis]
|
| 196 |
Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 197 |
Kozieł MJ, Ziaja M, Piastowska-Ciesielska AW. Intestinal Barrier, Claudins and Mycotoxins. Toxins (Basel) 2021;13:758. [PMID: 34822542 DOI: 10.3390/toxins13110758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 198 |
Yuan Z, Wang X, Geng X, Li Y, Tan F, Xue Q, Gao S, He J. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA. Cancer Genet 2021;258-259:93-100. [PMID: 34688997 DOI: 10.1016/j.cancergen.2021.08.005] [Reference Citation Analysis]
|
| 199 |
Wang Y, Xiao P, Yang N, Wang X, Ma K, Wu L, Zhang W, Zhuang X, Xie T, Fang Q, Lan M, Wang Q, Peng L. Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma. World J Surg Oncol 2021;19:303. [PMID: 34657600 DOI: 10.1186/s12957-021-02412-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 200 |
Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, Lou D, Hu L, Dai X, Guo F, Liu F. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale 2021;13:16457-64. [PMID: 34648610 DOI: 10.1039/d1nr04015d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 201 |
Shi Z, Zhu X, Ke S, Qiu H, Cai G, Zhangcai Y, Chen Y. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiother Oncol 2021;164:236-44. [PMID: 34627936 DOI: 10.1016/j.radonc.2021.09.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 202 |
Li C, Liu F, Yang X, Guo B, Li G, Yin J, He G, Yang C, Xu L, Li S, Wu H, Liu H, Ruan Y, Gu J, Wang L. Targeting lectin-like oxidized low-density lipoprotein receptor-1 triggers autophagic program in esophageal cancer. Cell Death Differ 2021. [PMID: 34611296 DOI: 10.1038/s41418-021-00884-y] [Reference Citation Analysis]
|
| 203 |
Kennedy SA, Annett SL, Dunne MR, Boland F, O'Neill LM, Guinan EM, Doyle SL, Foley EK, Elliott JA, Murphy CF, Bennett AE, Carey M, Hillary D, Robson T, Reynolds JV, Hussey J, O'Sullivan J. Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors. Front Oncol 2021;11:669078. [PMID: 34604026 DOI: 10.3389/fonc.2021.669078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 204 |
Peters Y, van Grinsven E, Siersema PD. Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther 2021;54:868-79. [PMID: 34383966 DOI: 10.1111/apt.16558] [Reference Citation Analysis]
|
| 205 |
Shao CY, Yu Y, Li QF, Liu XL, Song HZ, Shen Y, Yi J. Development and Validation of a Clinical Prognostic Nomogram for Esophageal Adenocarcinoma Patients. Front Oncol 2021;11:736573. [PMID: 34540700 DOI: 10.3389/fonc.2021.736573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 206 |
Cui Y, Zhang C, Ma S, Li Z, Wang W, Li Y, Ma Y, Fang J, Wang Y, Cao W, Guan F. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2021;40:294. [PMID: 34544449 DOI: 10.1186/s13046-021-02096-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 207 |
Chen S, Shen Z, Gao L, Yu S, Zhang P, Han Z, Kang M. TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9. Ann Transl Med 2021;9:1338. [PMID: 34532475 DOI: 10.21037/atm-21-4043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 208 |
Han J, Wang L, Zhang H, Ma S, Li Y, Wang Z, Zhu G, Zhao D, Wang J, Xue F. Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study. Front Oncol 2021;11:729471. [PMID: 34527592 DOI: 10.3389/fonc.2021.729471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 209 |
Saviaro H, Rintala J, Kauppila JH, Yannopoulos F, Meriläinen S, Koivukangas V, Huhta H, Helminen O, Saarnio J. Thirty years of esophageal cancer surgery in Oulu University Hospital. J Thorac Dis 2021;13:4638-49. [PMID: 34527305 DOI: 10.21037/jtd-21-520] [Reference Citation Analysis]
|
| 210 |
Dighe SG, Yan L, Mukherjee S, McGillicuddy CS, Hulme KL, Hochwald SN, Yendamuri S, Bain AJ, Robillard KT, Moysich KB, Ambrosone CB, Millen AE, Buas MF. Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center. Cancers (Basel) 2021;13:4653. [PMID: 34572881 DOI: 10.3390/cancers13184653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 211 |
Xu J, Liu X, Liu X, Zhi Y. Long noncoding RNA KCNMB2-AS1 promotes the development of esophageal cancer by modulating the miR-3194-3p/PYGL axis. Bioengineered 2021;12:6687-702. [PMID: 34516362 DOI: 10.1080/21655979.2021.1973775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 212 |
Wang X, Hobbs B, Gandhi SJ, Muijs CT, Langendijk JA, Lin SH. Current status and application of proton therapy for esophageal cancer. Radiother Oncol 2021;164:27-36. [PMID: 34534613 DOI: 10.1016/j.radonc.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 213 |
Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 214 |
Fang X, Shrestha SM, Ren LH, Shi RH. Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma. FEBS Open Bio 2021;11:2870-87. [PMID: 34510785 DOI: 10.1002/2211-5463.13297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 215 |
Min Q, Wang Y, Wu Q, Li X, Teng H, Fan J, Cao Y, Fan P, Zhan Q. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma. JCI Insight 2021;6:150203. [PMID: 34494553 DOI: 10.1172/jci.insight.150203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 216 |
Bai Y, Zhu P, Zhou K, Zhang SG. Effect of the acid suppressor omeprazole on the proliferation, migration, invasion and cell cycle of esophageal squamous cell carcinoma cells via the aryl hydrocarbon receptor pathway. Exp Ther Med 2021;22:1187. [PMID: 34475977 DOI: 10.3892/etm.2021.10621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 217 |
Liu Y, Pettersson E, Schandl A, Markar S, Johar A, Lagergren P. Psychological distress after esophageal cancer surgery and the predictive effect of dispositional optimism: a nationwide population-based longitudinal study. Support Care Cancer 2021. [PMID: 34480622 DOI: 10.1007/s00520-021-06517-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 218 |
Kato T, Oshikiri T, Goto H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy. J Surg Oncol 2021;124:1022-30. [PMID: 34460103 DOI: 10.1002/jso.26611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 219 |
Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021;6:322. [PMID: 34462423 DOI: 10.1038/s41392-021-00735-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 220 |
Berman AG, Fitzgerald RC, Markowetz F. A composite biomarker for esophageal cancer risk from automated analysis of a non-endoscopic device.. [DOI: 10.1101/2021.08.20.21262366] [Reference Citation Analysis]
|
| 221 |
Zhang D, Guo L, Wu X, Luo M, Liang X, Jiang C, Wang T, Gao Y, Zou Q. Identifying and Verifying AR, ERBB2, and VEGFA Are the Targets of Qigesan in the Treatment of Esophageal Adenocarcinoma In Silico and In Vitro. Scientific Programming 2021;2021:1-15. [DOI: 10.1155/2021/5463724] [Reference Citation Analysis]
|
| 222 |
Nowicki-Osuch K, Zhuang L, Jammula S, Bleaney CW, Mahbubani KT, Devonshire G, Katz-Summercorn A, Eling N, Wilbrey-Clark A, Madissoon E, Gamble J, Di Pietro M, O'Donovan M, Meyer KB, Saeb-Parsy K, Sharrocks AD, Teichmann SA, Marioni JC, Fitzgerald RC. Molecular phenotyping reveals the identity of Barrett's esophagus and its malignant transition. Science 2021;373:760-7. [PMID: 34385390 DOI: 10.1126/science.abd1449] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 223 |
Wen L, Mao W, Xu L, Cai B, Gu L. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. Chem Biol Drug Des 2021. [PMID: 34411455 DOI: 10.1111/cbdd.13937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 224 |
Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 [PMID: 34457187 DOI: 10.4251/wjgo.v13.i8.799] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 225 |
Pickering OJ, Breininger SP, Underwood TJ, Walters ZS. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma. Cancers (Basel) 2021;13:4084. [PMID: 34439236 DOI: 10.3390/cancers13164084] [Reference Citation Analysis]
|
| 226 |
Wolfson P, Ho KMA, Bassett P, Haidry R, Olivo A, Lovat L, Sami SS. Accuracy of clinical staging for T2N0 oesophageal cancer: systematic review and meta-analysis. Dis Esophagus 2021;34:doab002. [PMID: 33618359 DOI: 10.1093/dote/doab002] [Reference Citation Analysis]
|
| 227 |
Peters Y, Huibertse LJ, Schrauwen RWM, Tan AC, van der Post RS, Siersema PD. Increased risk of Barrett's oesophagus and related neoplasia in individuals with a positive family history. Eur J Cancer 2021;155:116-26. [PMID: 34375895 DOI: 10.1016/j.ejca.2021.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 228 |
Wan J, Niu C, Wang B, Han Q, Chen Y, Feng S, Yang L. Human esophageal fibroblast-derived exosomal miR-21 reduced the cisplatin sensitivity to esophageal carcinoma EC9706 cells. Braz J Med Biol Res 2021;54:e11156. [PMID: 34378676 DOI: 10.1590/1414-431X2021e11156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 229 |
Ye B, Fan D, Xiong W, Li M, Yuan J, Jiang Q, Zhao Y, Lin J, Liu J, Lv Y, Wang X, Li Z, Su J, Qiao Y. Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis. Nat Commun 2021;12:4457. [PMID: 34294701 DOI: 10.1038/s41467-021-24813-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 230 |
Su Z, Gao A, Li X, Zou S, He C, Wu J, Ding WQ, Zhou J. DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation. Front Oncol 2021;11:706337. [PMID: 34354953 DOI: 10.3389/fonc.2021.706337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 231 |
Xia YC, Cao J, Yang J, Zhang Y, Li YS. lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p. Dis Markers 2021;2021:2217663. [PMID: 34336002 DOI: 10.1155/2021/2217663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 232 |
Duan L, Cao L, Zhang R, Niu L, Yang W, Feng W, Zhou W, Chen J, Wang X, Li Y, Zhang Y, Liu J, Zhao Q, Fan D, Hong L. Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes. Bioengineered 2021;12:3434-54. [PMID: 34252349 DOI: 10.1080/21655979.2021.1946235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 233 |
Xu YY, Zhou XL, Yu CH, Wang WW, Ji FZ, He DC, Zhu WG, Tong YS. Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. Front Oncol 2021;11:655071. [PMID: 34307131 DOI: 10.3389/fonc.2021.655071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 234 |
Niu Z, Zhang W, Shi J, Li X, Wu H. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation. J Cardiothorac Surg 2021;16:194. [PMID: 34233689 DOI: 10.1186/s13019-021-01540-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 235 |
Izadi F, Sharpe BP, Breininger SP, Secrier M, Gibson J, Walker RC, Rahman S, Devonshire G, Lloyd MA, Walters ZS, Fitzgerald RC, Rose-Zerilli MJJ, Underwood TJ, On Behalf Of Occams. Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancers (Basel) 2021;13. [PMID: 34298611 DOI: 10.3390/cancers13143394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 236 |
Baxter MA, Middleton F, Cagney HP, Petty RD. Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers. Br J Cancer 2021. [PMID: 34230609 DOI: 10.1038/s41416-021-01425-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 237 |
Maehara O, Suda G, Natsuizaka M, Shigesawa T, Kanbe G, Kimura M, Sugiyama M, Mizokami M, Nakai M, Sho T, Morikawa K, Ogawa K, Ohashi S, Kagawa S, Kinugasa H, Naganuma S, Okubo N, Ohnishi S, Takeda H, Sakamoto N. FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma. Cancer Biol Ther 2021;22:372-80. [PMID: 34224333 DOI: 10.1080/15384047.2021.1939638] [Reference Citation Analysis]
|
| 238 |
Killcoyne S, Yusuf A, Fitzgerald RC. Genomic instability signals offer diagnostic possibility in early cancer detection. Trends Genet 2021:S0168-9525(21)00165-7. [PMID: 34218956 DOI: 10.1016/j.tig.2021.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 239 |
Ito R, Kadota T, Murano T, Yoda Y, Hori K, Minamide T, Sato D, Yamamoto Y, Takashima K, Shinmura K, Ikematsu H, Yano T. Clinical features and risk factors of gastric cancer detected by esophagogastroduodenoscopy in esophageal cancer patients. Esophagus 2021;18:621-8. [PMID: 33630192 DOI: 10.1007/s10388-021-00822-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 240 |
Chen X, Zhang Y, Shi Y, Niu T, Li B, Guo L, Qiao Y, Zhao J, Yuan B, Liu K. Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX. Analyst 2021;146:4180-7. [PMID: 34105524 DOI: 10.1039/d1an00634g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 241 |
Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res 2021. [PMID: 34173992 DOI: 10.1002/ptr.7119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 242 |
Zhang H, Qin G, Zhang C, Yang H, Liu J, Hu H, Wu P, Liu S, Yang L, Chen X, Zhao X, Wang L, Zhang Y. TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas. J Exp Clin Cancer Res 2021;40:209. [PMID: 34167551 DOI: 10.1186/s13046-021-01972-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 243 |
Zhang C, Lian H, Xie L, Yin N, Cui Y. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem 2020;401:1053-61. [PMID: 32229685 DOI: 10.1515/hsz-2019-0430] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 244 |
Li H, Ding C, Zeng H, Zheng R, Cao M, Ren J, Shi J, Sun D, He S, Yang Z, Yu Y, Zhang Z, Sun X, Guo G, Song G, Wei W, Chen W, He J. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China. Cancer Commun (Lond) 2021;41:715-25. [PMID: 34146456 DOI: 10.1002/cac2.12186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 245 |
Zhao Q, Huang L, Qin G, Qiao Y, Ren F, Shen C, Wang S, Liu S, Lian J, Wang D, Yu W, Zhang Y. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Lett 2021;518:35-48. [PMID: 34139285 DOI: 10.1016/j.canlet.2021.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 246 |
Huang S, Yang T, Wang W, Huang G, Chen B, Chen P, Ke D, Huang W, Xie J. Thoracoscopic radical esophagectomy combined with left inferior pulmonary ligament lymphadenectomy for esophageal carcinoma via the right thoracic approach: A single-center retrospective study of 30 cases. Medicine (Baltimore) 2021;100:e26302. [PMID: 34115038 DOI: 10.1097/MD.0000000000026302] [Reference Citation Analysis]
|
| 247 |
Hayashi M, Abe M, Fujita T, Matsushita H. Assessing the Prognostic Value of Extranodal Extension in Esophageal Cancer from the Pathological Staging Perspective. J Invest Surg 2021;:1-9. [PMID: 34096439 DOI: 10.1080/08941939.2021.1912221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 248 |
Dlamini Z, Hull R, Mbatha SZ, Alaouna M, Qiao YL, Yu H, Chatziioannou A. Prognostic Alternative Splicing Signatures in Esophageal Carcinoma. Cancer Manag Res 2021;13:4509-27. [PMID: 34113176 DOI: 10.2147/CMAR.S305464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 249 |
Wang G, Guo S, Zhang W, Li D, Wang Y, Zhan Q. Co-expression network analysis identifies key modules and hub genes implicated in esophageal squamous cell cancer progression. Medicine in Omics 2021;1:100003. [DOI: 10.1016/j.meomic.2020.100003] [Reference Citation Analysis]
|
| 250 |
Xie SH, Santoni G, Mälberg K, Lagergren P, Lagergren J. Prediction Model of Long-term Survival After Esophageal Cancer Surgery. Ann Surg 2021;273:933-9. [PMID: 33824250 DOI: 10.1097/SLA.0000000000003431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 251 |
Liang LQ, Meng LL, Cai BN, Cui ZP, Ma N, Du LH, Yu W, Qu BL, Feng SQ, Liu F. Changes in the nutritional status of nine vitamins in patients with esophageal cancer during chemotherapy. World J Gastroenterol 2021; 27(19): 2366-2375 [PMID: 34040328 DOI: 10.3748/wjg.v27.i19.2366] [Reference Citation Analysis]
|
| 252 |
Venkitachalam S, Babu D, Ravillah D, Katabathula RM, Joseph P, Singh S, Udhayakumar B, Miao Y, Martinez-uribe O, Hogue JA, Kresak AM, Dawson D, Laframboise T, Willis JE, Chak A, Garman KS, Blum AE, Varadan V, Guda K. The EphB2-MYC Axis is a Major Determinant of Barrett’s Pathobiology and a Therapeutic Vulnerability in Esophageal Cancer.. [DOI: 10.1101/2021.05.13.444044] [Reference Citation Analysis]
|
| 253 |
Hu Y, Liu F, Jia X, Wang P, Gu T, Liu H, Liu T, Wei H, Chen H, Zhao J, Yang R, Chen Y, Dong Z, Liu K. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3. Oncogene 2021;40:3942-58. [PMID: 33986510 DOI: 10.1038/s41388-021-01817-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 254 |
Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Front Immunol 2021;12:669750. [PMID: 34054840 DOI: 10.3389/fimmu.2021.669750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 255 |
Ma F, Laster K, Nie W, Liu F, Kim DJ, Lee MH, Bai R, Yang R, Liu K, Dong Z. Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts. J Cancer 2021;12:3930-44. [PMID: 34093800 DOI: 10.7150/jca.52286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 256 |
Wakiyama H, Kato T, Furusawa A, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy of cancer; possible clinical applications. Nanophotonics 2021;10:3135-51. [DOI: 10.1515/nanoph-2021-0119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 257 |
Peng W, Tu G, Zhao Z, He B, Cai Q, Zhang P, Peng X, Shi S, Wang X. DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection. PeerJ 2021;9:e11355. [PMID: 34012728 DOI: 10.7717/peerj.11355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 258 |
Wu J, Yang J, Lin X, Lin L, Jiang W, Xie C. Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis. Transl Cancer Res 2021;10:2144-52. [PMID: 35116534 DOI: 10.21037/tcr-20-2995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 259 |
Wang W, Chen D, Sang Y, Chen C, Zhang Y, Mao Y, Chen Y. Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study. Clin Res Hepatol Gastroenterol 2021;45:101543. [PMID: 33554864 DOI: 10.1016/j.clinre.2020.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 260 |
Xie CY, Hu YH, Ho JW, Han LJ, Yang H, Wen J, Lam KO, Wong IY, Law SY, Chiu KW, Fu JH, Vardhanabhuti V. Using Genomics Feature Selection Method in Radiomics Pipeline Improves Prognostication Performance in Locally Advanced Esophageal Squamous Cell Carcinoma-A Pilot Study. Cancers (Basel) 2021;13:2145. [PMID: 33946826 DOI: 10.3390/cancers13092145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 261 |
Qian H, Ji X, Liu C, Dang Y, Li X, Zhang G. Clinical Characteristics, Prognosis, and Nomogram for Esophageal Cancer Based on Adenosquamous Carcinoma: A SEER Database Analysis. Front Oncol 2021;11:603349. [PMID: 33981595 DOI: 10.3389/fonc.2021.603349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 262 |
Jonckheere N, Vincent A, Neve B, Van Seuningen I. Mucin expression, epigenetic regulation and patient survival: A toolkit of prognostic biomarkers in epithelial cancers. Biochim Biophys Acta Rev Cancer 2021;1876:188538. [PMID: 33862149 DOI: 10.1016/j.bbcan.2021.188538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 263 |
Xu M, Song J. Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era. Front Pharmacol 2021;12:623674. [PMID: 33935716 DOI: 10.3389/fphar.2021.623674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 264 |
Gehrung M, Crispin-Ortuzar M, Berman AG, O'Donovan M, Fitzgerald RC, Markowetz F. Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning. Nat Med 2021;27:833-41. [PMID: 33859411 DOI: 10.1038/s41591-021-01287-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 265 |
Woodfield G, Belluomo I, Boshier PR, Waller A, Fayyad M, von Wagner C, Cross AJ, Hanna GB. Feasibility and acceptability of breath research in primary care: a prospective, cross-sectional, observational study. BMJ Open 2021;11:e044691. [PMID: 33849851 DOI: 10.1136/bmjopen-2020-044691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 266 |
Yarrarapu SNS, Govero AB, Kukhon FR, Sanghavi DK. Rare presentation of subglottic soft-tissue swelling following FOLFOX therapy in a patient with metastatic oesophageal cancer. BMJ Case Rep 2021;14:e240938. [PMID: 33849874 DOI: 10.1136/bcr-2020-240938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 267 |
Kanie Y, Okamura A, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33839977 DOI: 10.1245/s10434-021-09945-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 268 |
Qian X, Zhang D, Cao Z, Ma H. Dopamine Pathway Mediated by DRD5 Facilitates Tumor Growth via Enhancing Warburg Effect in Esophageal Cancer. Front Oncol 2021;11:655861. [PMID: 33898321 DOI: 10.3389/fonc.2021.655861] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 269 |
Gopal A, Xi Y, Subramaniam RM, Pinho DF. Intratumoral Metabolic Heterogeneity and Other Quantitative 18F-FDG PET/CT Parameters for Prognosis Prediction in Esophageal Cancer. Radiol Imaging Cancer 2021;3:e200022. [PMID: 33778756 DOI: 10.1148/rycan.2020200022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 270 |
Zhang XM, Wang J, Liu ZL, Liu H, Cheng YF, Wang T. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway. Biosci Rep 2020;40:BSR20200525. [PMID: 32426838 DOI: 10.1042/BSR20200525] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 271 |
Cao Y, Gao A, Li X, Min H, He C, Sun X, Ding WQ, Zhou J. Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2-M checkpoint modulation. Cancer Med 2021;10:3101-12. [PMID: 33787085 DOI: 10.1002/cam4.3879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 272 |
O'Neill C, Cassidy FC, O'Shea D, Hogan AE. Mucosal Associated Invariant T Cells in Cancer-Friend or Foe? Cancers (Basel) 2021;13:1582. [PMID: 33808058 DOI: 10.3390/cancers13071582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 273 |
Izadi F, Sharpe BP, Breininger SP, Secrier M, Gibson J, Walker R, Rahman S, Devonshire G, Lloyd MA, Walters ZS, Fitzgerald RC, Rose-zerilli MJJ, Underwood TJ. Genomic analysis of response to neoadjuvant chemotherapy in esophageal adenocarcinoma.. [DOI: 10.1101/2021.03.26.437144] [Reference Citation Analysis]
|
| 274 |
Gotovac JR, Kader T, Milne JV, Fujihara KM, Lara-Gonzalez LE, Gorringe KL, Kalimuthu SN, Jayawardana MW, Duong CP, Phillips WA, Clemons NJ. Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's Esophagus. Cell Mol Gastroenterol Hepatol 2021;12:689-713. [PMID: 33774196 DOI: 10.1016/j.jcmgh.2021.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 275 |
Ma H, Song X, Li J, Zhao G. Application of mediastinal drainage tube in intrathoracic esophageal anastomotic leakage for early diagnosis and effective treatment: a retrospective study. J Cardiothorac Surg 2021;16:52. [PMID: 33766053 DOI: 10.1186/s13019-021-01435-9] [Reference Citation Analysis]
|
| 276 |
Ye J, Zhang L, Li Z, Lin R, Song Y, Ni H, Gou X, Xie R. High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2733-44. [PMID: 33790647 DOI: 10.2147/CMAR.S280326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 277 |
Davern M, Donlon NE, Sheppard A, Connell FO, Hayes C, Bhardwaj A, Foley E, Toole DO, Lynam-Lennon N, Ravi N, Reynolds JV, Maher SG, Lysaght J. Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells. Transl Oncol 2021;14:101062. [PMID: 33765543 DOI: 10.1016/j.tranon.2021.101062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 278 |
Jones CM, Lyles A, Foley KG. A national cross-sectional survey investigating the use of endoscopic ultrasound in the diagnosis and treatment of oesophageal cancer in the UK. Clin Radiol 2021;76:458-64. [PMID: 33752881 DOI: 10.1016/j.crad.2021.02.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 279 |
Sun X, Sun Y, Li J, Zhao X, Shi X, Gong T, Pan S, Zheng Z, Zhang X. SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation. Cancer Cell Int 2021;21:165. [PMID: 33712005 DOI: 10.1186/s12935-021-01859-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 280 |
Wu X, Zhang H, Sui Z, Wang Y, Yu Z. The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biol Med 2021:j. [PMID: 33710803 DOI: 10.20892/j.issn.2095-3941.2020.0140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 281 |
Murakami T, Shoji Y, Nishi T, Chang SC, Jachimowicz RD, Hoshimoto S, Ono S, Shiloh Y, Takeuchi H, Kitagawa Y, Hoon DSB, Bustos MA. Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma. Mol Oncol 2021;15:1069-87. [PMID: 33605536 DOI: 10.1002/1878-0261.12929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 282 |
Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2223-34. [PMID: 33707971 DOI: 10.2147/CMAR.S295927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 283 |
Zhao S, Sun N, Yuan X, Shen Z, Zhu X, Li J. Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report. Medicine (Baltimore) 2021;100:e24462. [PMID: 33655918 DOI: 10.1097/MD.0000000000024462] [Reference Citation Analysis]
|
| 284 |
Wang X, Kutschat AP, Yamada M, Prokakis E, Böttcher P, Tanaka K, Doki Y, Hamdan FH, Johnsen SA. Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas. Cell Death Differ 2021;28:2207-20. [PMID: 33658703 DOI: 10.1038/s41418-021-00751-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 285 |
Kayamba V. Nutrition and upper gastrointestinal cancers: An overview of current understandings. Seminars in Cancer Biology 2021. [DOI: 10.1016/j.semcancer.2021.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 286 |
Chen Z, Che D, Gu X, Lin J, Deng J, Jiang P, Xu K, Xu B, Zhang T. Upregulation of PEDF Predicts a Poor Prognosis and Promotes Esophageal Squamous Cell Carcinoma Progression by Modulating the MAPK/ERK Signaling Pathway. Front Oncol 2021;11:625612. [PMID: 33718190 DOI: 10.3389/fonc.2021.625612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 287 |
Yang W, Chen CH, Jia M, Xing X, Gao L, Tsai HT, Zhang Z, Liu Z, Zeng B, Yeung SJ, Lee MH, Cheng C. Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:641270. [PMID: 33681225 DOI: 10.3389/fcell.2021.641270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 288 |
Wang Z, Chen M, Qiu Y, Yang Y, Huang Y, Li X, Zhang W. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment. Biosci Rep 2021;41:BSR20202439. [PMID: 33543230 DOI: 10.1042/BSR20202439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 289 |
de Jonge H, Iamele L, Maggi M, Pessino G, Scotti C. Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues. Cancers (Basel) 2021;13:813. [PMID: 33672007 DOI: 10.3390/cancers13040813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 290 |
Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WL. Esophageal Cancer: Tumor-Node-Metastasis Staging. Radiol Clin North Am 2021;59:219-29. [PMID: 33551083 DOI: 10.1016/j.rcl.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 291 |
Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, Zhang Y, Yuan Y. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Front Cell Dev Biol 2021;9:612451. [PMID: 33644048 DOI: 10.3389/fcell.2021.612451] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 292 |
Hryniewicz-Jankowska A, Wierzbicki J, Tabola R, Stach K, Sossey-Alaoui K, Augoff K. The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma. Int J Mol Sci 2021;22:1716. [PMID: 33572115 DOI: 10.3390/ijms22041716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 293 |
Ding J, Li C, Cheng Y, Du Z, Wang Q, Tang Z, Song C, Xia Q, Bai W, Lin L, Liu W, Xu L, Li E, Wu B. Alterations of RNA splicing patterns in esophagus squamous cell carcinoma. Cell Biosci 2021;11:36. [PMID: 33563334 DOI: 10.1186/s13578-021-00546-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 294 |
Cotton S, Ferreira D, Soares J, Peixoto A, Relvas-Santos M, Azevedo R, Piairo P, Diéguez L, Palmeira C, Lima L, Silva AMN, Lara Santos L, Ferreira JA. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness. Int J Mol Sci 2021;22:1664. [PMID: 33562270 DOI: 10.3390/ijms22041664] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 295 |
Estarabadi H, Atyabi SA, Tavakkoli S, Noormohammadi Z, Gholami MR, Ghiaseddin A, Irani S. Cold atmospheric plasma induced genotoxicity and cytotoxicity in esophageal cancer cells. Mol Biol Rep 2021;48:1323-33. [PMID: 33547994 DOI: 10.1007/s11033-021-06178-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 296 |
Han L, Pan C, Ni Q, Yu T. Case Report: Herceptin as a Potentially Valuable Adjuvant Therapy for a Patient With Human Epidermal Growth Factor Receptor 2-Positive Advanced Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:600459. [PMID: 33598429 DOI: 10.3389/fonc.2020.600459] [Reference Citation Analysis]
|
| 297 |
Donlon NE, Power R, Hayes C, Davern M, Reynolds JV, Lysaght J. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play. Int J Mol Sci 2021;22:1071. [PMID: 33499003 DOI: 10.3390/ijms22031071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 298 |
Shao CY, Liu XL, Yao S, Li ZJ, Cong ZZ, Luo J, Dong GH, Yi J. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: Application of the nomogram. Eur J Surg Oncol 2021;47:1473-80. [PMID: 33349524 DOI: 10.1016/j.ejso.2020.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 299 |
Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, Zheng Y, Bai R, Zhuang L, Li M, Pan L, Deng J, Li R, Deng S, Zhang S, Zuo Z, Liu Z, Lin J, Lin D, Zheng J. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene 2021;40:5814-28. [PMID: 34345012 DOI: 10.1038/s41388-021-01978-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 300 |
Zeng YZ, Zhang YQ, Lin XQ, Chen JY, Zhang F, Zhu JL, Wei XL. Co-expression of VEGF-C and survivin predicts poor prognosis in esophageal squamous cell carcinoma. Transl Cancer Res 2021;10:210-22. [PMID: 35116253 DOI: 10.21037/tcr-20-2498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 301 |
Chen T, Zhang L, Huang X, Chen H, Zhu S, Huang C, Huang B. Exploring the Potential Pharmacologic Mechanism of Heterophyllin B in the Treatment of Esophageal Cancer by Network Pharmacology. E3S Web Conf 2021;271:03036. [DOI: 10.1051/e3sconf/202127103036] [Reference Citation Analysis]
|
| 302 |
Sinonquel P, Eelbode T, Bossuyt P, Maes F, Bisschops R. Artificial intelligence and its impact on quality improvement in upper and lower gastrointestinal endoscopy. Dig Endosc 2021;33:242-53. [PMID: 33145847 DOI: 10.1111/den.13888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 303 |
Koh CJ, Ho KY. Endoscopic Technologies for Diagnosing and Staging Early GI Cancers: Endoscopic Ultrasonography in GI Diseases. Endoscopy in Early Gastrointestinal Cancers, Volume 1 2021. [DOI: 10.1007/978-981-10-6769-3_15] [Reference Citation Analysis]
|
| 304 |
Liu S, Jiang H, Min L, Ning T, Xu J, Wang T, Wang X, Zhang Q, Cao R, Zhang S, Zhu S. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. Carcinogenesis 2021;42:611-20. [PMID: 33367557 DOI: 10.1093/carcin/bgaa143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 305 |
Wu C, Huang H, Choi HY, Ma Y, Zhou T, Peng Y, Pang K, Shu G, Yang X. Anti-esophageal Cancer Effect of Corilagin Extracted from Phmllanthi Fructus via the Mitochondrial and Endoplasmic Reticulum Stress Pathways. J Ethnopharmacol 2021;269:113700. [PMID: 33346026 DOI: 10.1016/j.jep.2020.113700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 306 |
Sato S, Fushimi S, Tahata Y, Mizutamari H, Mimori N, Kato Y, Horikawa Y. Feasibility of Endoscopic Screening for Upper Gastrointestinal Malignancy in a Comprehensive Health Checkup. Intern Med 2021;60:1493-9. [PMID: 33328405 DOI: 10.2169/internalmedicine.6020-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 307 |
Zhang D, Qian C, Wei H, Qian X. Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma. Front Mol Biosci 2020;7:599475. [PMID: 33381521 DOI: 10.3389/fmolb.2020.599475] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 308 |
Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, Palles C, Ye W, Gammon MD, Iyer PG, Anderson LA, Liu G, Wu AH, Dai JY, Chow WH, Risch HA, Lagergren J, Shaheen NJ, Bernstein L, Corley DA, Prenen H, deCaestecker J, MacDonald D, Moayyedi P, Barr H, Love SB, Chegwidden L, Attwood S, Watson P, Harrison R, Ott K, Moebus S, Venerito M, Lang H, Mayershofer R, Knapp M, Veits L, Gerges C, Weismüller J, Gockel I, Vashist Y, Nöthen MM, Izbicki JR, Manner H, Neuhaus H, Rösch T, Böhmer AC, Hölscher AH, Anders M, Pech O, Schumacher B, Schmidt C, Schmidt T, Noder T, Lorenz D, Vieth M, May A, Hess T, Kreuser N, Becker J, Ell C, Ambrosone CB, Moysich KB, MacGregor S, Tomlinson I, Whiteman DC, Jankowski J, Schumacher J, Vaughan TL, Madeleine MM, Hardie LJ, Buas MF. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis 2021;42:369-77. [PMID: 33300568 DOI: 10.1093/carcin/bgaa132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 309 |
Yuan Z, Wang X, Geng X, Li Y, Mu J, Tan F, Xue Q, Gao S, He J. Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible? Cancer Commun (Lond) 2021;41:3-15. [PMID: 33264481 DOI: 10.1002/cac2.12118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 310 |
He Y, Hua R, Li B, Gu H, Sun Y, Li Z. Loss of FBP1 promotes proliferation, migration, and invasion by regulating fatty acid metabolism in esophageal squamous cell carcinoma. Aging (Albany NY) 2020;13:4986-98. [PMID: 33232284 DOI: 10.18632/aging.103916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 311 |
Zhang D, Wu J, Wang H, Zhou W, Ni M, Liu X, Zhang X. Systematic review and network meta-analysis comparing Chinese herbal injections with chemotherapy for treating patients with esophageal cancer. J Int Med Res 2020;48:300060519898336. [PMID: 31948305 DOI: 10.1177/0300060519898336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 312 |
Wei L, Wang B, Hu L, Xu Y, Li Z, Shen Y, Huang H. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6. Aging (Albany NY) 2020;12:21091-113. [PMID: 33188661 DOI: 10.18632/aging.103196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 313 |
Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines. Cancers (Basel) 2020;12:E3356. [PMID: 33202734 DOI: 10.3390/cancers12113356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 314 |
Wang G, Guo S, Zhang W, Li Z, Xu J, Li D, Wang Y, Zhan Q. A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer. Front Oncol 2020;10:575711. [PMID: 33178606 DOI: 10.3389/fonc.2020.575711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 315 |
Hua XY, Bie XX, Cheng X, Zhang SG. High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma. Mol Med Rep 2021;23:12. [PMID: 33179079 DOI: 10.3892/mmr.2020.11650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 316 |
Mima K, Kosumi K, Baba Y, Hamada T, Baba H, Ogino S. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. Hum Genet 2021;140:725-46. [PMID: 33180176 DOI: 10.1007/s00439-020-02235-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 317 |
Luo QY, Zhou SN, Pan WT, Sun J, Yang LQ, Zhang L, Qiu MZ, Yang DJ. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. Biochem Pharmacol 2021;183:114318. [PMID: 33159967 DOI: 10.1016/j.bcp.2020.114318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 318 |
Gironda DJ, Adams DL, He J, Xu T, Gao H, Qiao Y, Komaki R, Reuben JM, Liao Z, Blum-Murphy M, Hofstetter WL, Tang CM, Lin SH. Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy. J Transl Med 2020;18:413. [PMID: 33148307 DOI: 10.1186/s12967-020-02563-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 319 |
de Jong JJ, Lantinga MA, Thijs IME, de Reuver PR, Drenth JPH. Systematic review with meta-analysis: age-related malignancy detection rates at upper gastrointestinal endoscopy. Therap Adv Gastroenterol 2020;13:1756284820959225. [PMID: 33209123 DOI: 10.1177/1756284820959225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 320 |
Griffin N, Gao F, Jobling P, Oldmeadow C, Wills V, Walker MM, Faulkner S, Hondermarck H. The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma. Pathology 2021;53:470-7. [PMID: 33143904 DOI: 10.1016/j.pathol.2020.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 321 |
Wei B, Xu L, Hui H, Sun Y, Wu J. USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy. Clin Res Hepatol Gastroenterol 2020;44:932-8. [PMID: 31983659 DOI: 10.1016/j.clinre.2019.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 322 |
Xiao J, Zhang Y, Fang T, Yuan T, Tian Q, Liu J, Cheng Y, Zhu Y, Cheng L, Cui W. Mineralized manganese dioxide channel as the stent coating for in situ precise tumor navigation. Nano Res 2020. [DOI: 10.1007/s12274-020-3114-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 323 |
Zaparte A, Cappellari AR, Brandão CA, de Souza JB, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Ribeiro Pinto LF, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. Eur J Pharmacol 2021;891:173687. [PMID: 33130276 DOI: 10.1016/j.ejphar.2020.173687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 324 |
Zhao M, Cui H, Zhao B, Li M, Man H. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:2007-18. [PMID: 33125097 DOI: 10.3892/ijmm.2020.4750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 325 |
Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther 2020;5:229. [PMID: 33028804 DOI: 10.1038/s41392-020-00323-3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 94] [Article Influence: 28.0] [Reference Citation Analysis]
|
| 326 |
Vale N, Duarte D, Silva S, Correia AS, Costa B, Gouveia MJ, Ferreira A. Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacol Res 2020;162:105231. [PMID: 33027717 DOI: 10.1016/j.phrs.2020.105231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 327 |
Zhang C, Luo Y, Cao J, Wang X, Miao Z, Shao G. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR-206 to upregulate NETO2 and FOXP1 expression. Cancer Med 2020;9:8600-11. [PMID: 33006432 DOI: 10.1002/cam4.3463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 328 |
Feng H, Song G, Ma S, Ma Q, Li X, Wei W, Abnet C, Qiao Y, Wang G. The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China. J Gastroenterol Hepatol 2020;35:1761-8. [PMID: 32367575 DOI: 10.1111/jgh.15090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 329 |
Wan PK, Leung TH, Siu MK, Mo XT, Tang HW, Chan KK, Cheung AN, Ngan HY. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer. Cancer Lett 2021;497:14-27. [PMID: 33010383 DOI: 10.1016/j.canlet.2020.09.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 330 |
Guo H, Wang B, Xu K, Nie L, Fu Y, Wang Z, Wang Q, Wang S, Zou X. m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1. Front Oncol 2020;10:553045. [PMID: 33134163 DOI: 10.3389/fonc.2020.553045] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 331 |
Yu F, Wang X, Shi H, Jiang M, Xu J, Sun M, Xu Q, Addai FP, Shi H, Gu J, Zhou Y, Liu L. Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer. Tumori 2021;107:341-52. [PMID: 32988314 DOI: 10.1177/0300891620960223] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 332 |
Kim S, DiPeri TP, Guan M, Placencio-Hickok VR, Kim H, Liu JY, Hendifar A, Klempner SJ, Nipp R, Gangi A, Burch M, Waters K, Cho M, Chao J, Atkins K, Kamrava M, Tuli R, Gong J. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World J Gastrointest Surg 2020; 12(9): 377-389 [PMID: 33024512 DOI: 10.4240/wjgs.v12.i9.377] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 333 |
Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020;13:1010-21. [PMID: 32965635 DOI: 10.1007/s12328-020-01237-x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 97] [Article Influence: 38.7] [Reference Citation Analysis]
|
| 334 |
Baxter MA, Spender LC, Petty RD. Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma. Br J Cancer 2020;123:1585-7. [PMID: 32958821 DOI: 10.1038/s41416-020-01057-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 335 |
Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells. Int J Mol Sci 2020;21:E6854. [PMID: 32961992 DOI: 10.3390/ijms21186854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 336 |
Onishi S, Tajika M, Tanaka T, Yamada K, Abe T, Higaki E, Hosoi T, Inaba Y, Muro K, Shimizu M, Niwa Y. Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma. J Clin Med 2020;9:E2974. [PMID: 32942595 DOI: 10.3390/jcm9092974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 337 |
Zhang L, Gao Y, Zhang X, Guo M, Yang J, Cui H, Kong P, Niu X, Bi Y, Xu J, Yan T, Ma Y, Yang J, Qian Y, Wang F, Li H, Liu F, Cheng X, Cui Y. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics 2020;10:11339-58. [PMID: 33042286 DOI: 10.7150/thno.48225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 338 |
Pu S, Chen H, Zhou C, Yu S, Liao X, Zhu L, He J, Wang B. Major Postoperative Complications in Esophageal Cancer After Minimally Invasive Esophagectomy Compared With Open Esophagectomy: An Updated Meta-analysis. J Surg Res. 2021;257:554-571. [PMID: 32927322 DOI: 10.1016/j.jss.2020.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 339 |
Xiong Z, Wu J, Sun Y, Bai M, Niu F, Jin T. Variants in multiple genes are associated with esophageal cancer risk in a Chinese Han population: A case-control study. J Gene Med 2020;22:e3266. [PMID: 32864859 DOI: 10.1002/jgm.3266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 340 |
Wu Y, Wang X, Xu F, Zhang L, Wang T, Fu X, Jin T, Zhang W, Ye L. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth. Nucleic Acids Res 2020;48:4858-76. [PMID: 32313942 DOI: 10.1093/nar/gkaa232] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 341 |
Rogerson C, Ogden S, Britton E, Ang Y, Sharrocks AD; OCCAMS Consortium. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma. Elife 2020;9:e57189. [PMID: 32880368 DOI: 10.7554/eLife.57189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 342 |
Wang J, Zhu W, Tao G, Wang W. Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered 2020;11:932-8. [PMID: 32867570 DOI: 10.1080/21655979.2020.1809922] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 343 |
Lyu S, Lu J, Chen W, Huang W, Huang H, Xi S, Yan S. High expression of eIF4A2 is associated with a poor prognosis in esophageal squamous cell carcinoma. Oncol Lett 2020;20:177. [PMID: 32934744 DOI: 10.3892/ol.2020.12038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 344 |
Boldrin E, Curtarello M, Fassan M, Rugge M, Realdon S, Alfieri R, Amadori A, Saggioro D. Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment. Front Oncol 2020;10:1320. [PMID: 32983964 DOI: 10.3389/fonc.2020.01320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 345 |
Jiang K, He Y, Zhang X. Identification and Characterization of Copy Number-Associated Driver Genes in Esophageal Squamous Cell Carcinoma. Biomed Res Int 2020;2020:6387519. [PMID: 32908901 DOI: 10.1155/2020/6387519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 346 |
Wang X, Li K, Cheng M, Wang G, Han H, Chen F, Liao W, Chen Z, Chen J, Bao Y, Peng L, Chen D. Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma. Stem Cells Int 2020;2020:8877577. [PMID: 32884573 DOI: 10.1155/2020/8877577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 347 |
Chen Y, Wang H, Zhu S, Lan X. miR-483-5p promotes esophageal cancer progression by targeting KCNQ1. Biochem Biophys Res Commun 2020;531:615-21. [PMID: 32819715 DOI: 10.1016/j.bbrc.2020.07.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 348 |
Yu-Jing T, Wen-Jing T, Biao T. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Med Sci Monit 2020;26:e923934. [PMID: 32756534 DOI: 10.12659/MSM.923934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 349 |
Zhang L, Wang X, Liu X, Lv M, Shen E, Zhu G, Sun Z. miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer. Acta Biochim Biophys Sin (Shanghai) 2020;52:842-52. [PMID: 32645138 DOI: 10.1093/abbs/gmaa059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 350 |
Qian CJ, Xu ZR, Chen LY, Wang YC, Yao J. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis. Cancer Manag Res 2020;12:6895-908. [PMID: 32801913 DOI: 10.2147/CMAR.S262075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 351 |
Tang Q, Wu L, Xu M, Yan D, Shao J, Yan S. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer. Int J Radiat Oncol Biol Phys 2020;108:1368-79. [PMID: 32763454 DOI: 10.1016/j.ijrobp.2020.07.2322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 352 |
Cai H, Li Y, Qin D, Wang R, Tang Z, Lu T, Cui Y. The Depletion of ABI3BP by MicroRNA-183 Promotes the Development of Esophageal Carcinoma. Mediators Inflamm 2020;2020:3420946. [PMID: 32774142 DOI: 10.1155/2020/3420946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 353 |
Gehrung M, Crispin-ortuzar M, Berman AG, O’donovan M, Fitzgerald RC, Markowetz F. Triage-driven diagnosis for early detection of esophageal cancer using deep learning.. [DOI: 10.1101/2020.07.16.20154732] [Reference Citation Analysis]
|
| 354 |
Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Sci Rep 2020;10:11807. [PMID: 32678196 DOI: 10.1038/s41598-020-68713-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 355 |
Schizas D, Mylonas KS, Kapsampelis P, Bagias G, Katsaros I, Frountzas M, Hemmati P, Liakakos T. Patients undergoing surgery for oligometastatic oesophageal cancer survive for more than 2 years: bootstrapping systematic review data. Interactive CardioVascular and Thoracic Surgery 2020;31:299-304. [DOI: 10.1093/icvts/ivaa116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 356 |
Jiao R, Zheng X, Sun Y, Feng Z, Song S, Ge H. IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma. Front Oncol 2020;10:1099. [PMID: 32733806 DOI: 10.3389/fonc.2020.01099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 357 |
Xu LC, Pan JX, Pan HD. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.Cancer Manag Res. 2020;12:5385-5394. [PMID: 32753956 DOI: 10.2147/CMAR.S254870] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 358 |
Peters Y, Schrauwen RWM, Tan AC, Bogers SK, de Jong B, Siersema PD. Detection of Barrett's oesophagus through exhaled breath using an electronic nose device. Gut 2020;69:1169-72. [PMID: 32098798 DOI: 10.1136/gutjnl-2019-320273] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 359 |
Hou H, Zhao H, Yu X, Cong P, Zhou Y, Jiang Y, Cheng Y. METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway. Pathol Res Pract 2020;216:153087. [PMID: 32825955 DOI: 10.1016/j.prp.2020.153087] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 360 |
Maeda N, Shirakawa Y, Tanabe S, Sakurama K, Noma K, Fujiwara T. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor. World J Surg Oncol 2020;18:143. [PMID: 32591002 DOI: 10.1186/s12957-020-01908-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 361 |
Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, Willett C, Stiles B, Sharma P, Tang L, Wijnhoven BPL, Hofstetter WL. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol 2020;38:2677-94. [PMID: 32568633 DOI: 10.1200/JCO.20.00866] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 362 |
Zhu P, Yu H, Zhou K, Bai Y, Qi R, Zhang S. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway. J Exp Clin Cancer Res 2020;39:113. [PMID: 32546278 DOI: 10.1186/s13046-020-01618-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 363 |
Zhang L, Zhou S, Guo E, Chen X, Yang J, Li X. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Pflugers Arch 2020;472:1041-9. [PMID: 32533239 DOI: 10.1007/s00424-020-02415-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 364 |
Hou Y, Liu H, Pan W. Knockdown of circ_0003340 induces cell apoptosis, inhibits invasion and proliferation through miR-564/TPX2 in esophageal cancer cells. Exp Cell Res 2020;394:112142. [PMID: 32535036 DOI: 10.1016/j.yexcr.2020.112142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 365 |
Hou Q, Lin JC, Wu LF. Role of circular RNAs in digestive system malignancies. Shijie Huaren Xiaohua Zazhi 2020; 28(11): 417-427 [DOI: 10.11569/wcjd.v28.i11.417] [Reference Citation Analysis]
|
| 366 |
Li CL, Zhao JQ, Zang B. PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case-control study. J Clin Lab Anal 2020;34:e23406. [PMID: 32488984 DOI: 10.1002/jcla.23406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 367 |
Power R, Lowery MA, Reynolds JV, Dunne MR. The Cancer-Immune Set Point in Oesophageal Cancer. Front Oncol. 2020;10:891. [PMID: 32582553 DOI: 10.3389/fonc.2020.00891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 368 |
Hu J, Li R, Miao H, Wen Z. Identification of key genes for esophageal squamous cell carcinoma via integrated bioinformatics analysis and experimental confirmation. J Thorac Dis 2020;12:3188-99. [PMID: 32642240 DOI: 10.21037/jtd.2020.01.33] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 369 |
Wang Y, Ye D, Kang M, Zhu L, Pan S, Wang F. Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer. Cancer Manag Res 2020;12:3959-69. [PMID: 32547231 DOI: 10.2147/CMAR.S249810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 370 |
Jezerskyte E, Saadeh LM, Hagens ERC, Sprangers MAG, Noteboom L, van Laarhoven HWM, Eshuis WJ, Hulshof MCCM, van Berge Henegouwen MI, Gisbertz SS. Long-term health-related quality of life after McKeown and Ivor Lewis esophagectomy for esophageal carcinoma. Dis Esophagus 2020;33. [PMID: 32444879 DOI: 10.1093/dote/doaa022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 371 |
Yin S, Song M, Zhao R, Liu X, Kang WK, Lee JM, Kim YE, Zhang C, Shim JH, Liu K, Dong Z, Lee MH. Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo. Front Cell Dev Biol 2020;8:366. [PMID: 32509787 DOI: 10.3389/fcell.2020.00366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 372 |
Liang Y, Li S, Zheng G, Zhang L. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT. Acta Histochem 2020;122:151538. [PMID: 32183989 DOI: 10.1016/j.acthis.2020.151538] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 373 |
Jammula S, Katz-Summercorn AC, Li X, Linossi C, Smyth E, Killcoyne S, Biasci D, Subash VV, Abbas S, Blasko A, Devonshire G, Grantham A, Wronowski F, O'Donovan M, Grehan N, Eldridge MD, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) consortium. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data. Gastroenterology 2020;158:1682-1697.e1. [PMID: 32032585 DOI: 10.1053/j.gastro.2020.01.044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 374 |
Hua XY, Dong SY, Zhang SG. Meta-Analysis of Two Different Methods for Cervical Esophagogastric Anastomosis: Triangulating Versus Circular Stapling. J Laparoendosc Adv Surg Tech A 2020;30:1143-9. [PMID: 32315563 DOI: 10.1089/lap.2020.0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 375 |
Du F, Guo T, Cao C. Restoration of UPK1A-AS1 Expression Suppresses Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cell Carcinoma Cells Partially by Sponging microRNA-1248. Cancer Manag Res 2020;12:2653-62. [PMID: 32368143 DOI: 10.2147/CMAR.S239418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 376 |
Li Y, Li T, Yang Y, Kang W, Dong S, Cheng S. YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells. Cell Biol Int 2020;44:1447-57. [PMID: 32159250 DOI: 10.1002/cbin.11338] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 377 |
Guan L, Zou Q, Liu Q, Lin Y, Chen S. HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:2997-3011. [PMID: 32308431 DOI: 10.2147/OTT.S245813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 378 |
Zhang H, Lv H, Weng M, Wang H, Cata JP, Chen W, Miao C. Preoperative leukocytosis is associated with increased tumour-infiltrating neutrophil extracellular traps and worse outcomes in esophageal cancer.Ann Transl Med. 2020;8:441. [PMID: 32395485 DOI: 10.21037/atm.2020.03.190] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 379 |
Yang L, Shen C, Pettit CJ, Li T, Hu AJ, Miller ED, Zhang J, Lin SH, Williams TM. Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy. Clin Cancer Res 2020;26:3740-50. [PMID: 32220892 DOI: 10.1158/1078-0432.CCR-19-3373] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 380 |
Gao J, Zhang Z, Su H, Zong L, Li Y. Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression. Cancer Manag Res 2020;12:2265-78. [PMID: 32273764 DOI: 10.2147/CMAR.S236576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 381 |
Pietrzak AK, Martenka P, Strzesak E, Pietrasz K, Heydrych A, Pisarska B, Kucnerowicz K, Cholewiński W. Użyteczność i ograniczenia badania 18F-FDG PET/CT w diagnostyce nowotworu złośliwego przełyku. LOS 2020;17:47-51. [DOI: 10.21641/los.2020.17.1.170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 382 |
Göbel HH, Büttner-Herold MJ, Fuhrich N, Aigner T, Grabenbauer GG, Distel LVR. Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma. Radiother Oncol 2020;146:151-60. [PMID: 32169773 DOI: 10.1016/j.radonc.2020.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 383 |
Song M, Yoon G, Choi JS, Kim E, Liu X, Oh HN, Chae JI, Lee MH, Shim JH. Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth. Phytother Res 2020;34:2032-43. [PMID: 32144852 DOI: 10.1002/ptr.6661] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 384 |
Jepsen DNM, Fiehn AK, Svendsen B, Achiam MP, Federspiel B. Isolated tumor cells in the regional lymph nodes in patients with squamous cell carcinoma of the esophagus are rarely observed but often represent part of a true metastasis. Ann Diagn Pathol 2020;45:151478. [PMID: 32135481 DOI: 10.1016/j.anndiagpath.2020.151478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 385 |
Rogerson C, Ogden S, Britton E, Ang Y, Sharrocks AD, the OCCAMS consortium. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to Oesophageal Adenocarcinoma.. [DOI: 10.1101/2020.02.10.941872] [Reference Citation Analysis]
|
| 386 |
Shah MA, Kojima T, Hochhauser D, Enzinger P, Raimbourg J, Hollebecque A, Lordick F, Kim SB, Tajika M, Kim HT, Lockhart AC, Arkenau HT, El-Hajbi F, Gupta M, Pfeiffer P, Liu Q, Lunceford J, Kang SP, Bhagia P, Kato K. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study. JAMA Oncol. 2019;5:546-550. [PMID: 30570649 DOI: 10.1001/jamaoncol.2018.5441] [Cited by in Crossref: 238] [Cited by in F6Publishing: 266] [Article Influence: 79.3] [Reference Citation Analysis]
|
| 387 |
Su JF, Zhao F, Gao ZW, Hou YJ, Li YY, Duan LJ, Lun SM, Yang HJ, Li JK, Dai NT, Shen FF, Zhou FY. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathol Res Pract 2020;216:152848. [PMID: 32051106 DOI: 10.1016/j.prp.2020.152848] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 388 |
Kwak A, Choi J, Liu K, Lee M, Jeon Y, Cho S, Yoon G, Oh H, Chae J, Shim J. Licochalcone C induces cell cycle G1 arrest and apoptosis in human esophageal squamous carcinoma cells by activation of the ROS/MAPK signaling pathway. Journal of Chemotherapy 2020;32:132-43. [DOI: 10.1080/1120009x.2020.1721175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 389 |
Lordick F, Herrmann K. Metabolic response assessment and PET-guided treatment of esophageal cancer. Annals of Oncology 2020;31:163-164. [DOI: 10.1016/j.annonc.2019.11.008] [Reference Citation Analysis]
|
| 390 |
Martínez-Barriocanal Á, Arango D, Dopeso H. PVT1 Long Non-coding RNA in Gastrointestinal Cancer. Front Oncol 2020;10:38. [PMID: 32083000 DOI: 10.3389/fonc.2020.00038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 391 |
Noorani A, Li X, Goddard M, Crawte J, Alexandrov LB, Secrier M, Eldridge MD, Bower L, Weaver J, Lao-Sirieix P, Martincorena I, Debiram-Beecham I, Grehan N, MacRae S, Malhotra S, Miremadi A, Thomas T, Galbraith S, Petersen L, Preston SD, Gilligan D, Hindmarsh A, Hardwick RH, Stratton MR, Wedge DC, Fitzgerald RC. Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma. Nat Genet 2020;52:74-83. [PMID: 31907488 DOI: 10.1038/s41588-019-0551-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 392 |
张 云. Pathological Characteristics and Prognosis of Esophageal Cancer Based on SEER Database. ACM 2020;10:1500-1510. [DOI: 10.12677/acm.2020.107226] [Reference Citation Analysis]
|
| 393 |
Zhang R, Lau LHS, Wu PIC, Yip HC, Wong SH. Endoscopic Diagnosis and Treatment of Esophageal Squamous Cell Carcinoma. Methods Mol Biol 2020;2129:47-62. [PMID: 32056169 DOI: 10.1007/978-1-0716-0377-2_5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 394 |
de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 [PMID: 31885424 DOI: 10.3748/wjg.v25.i47.6835] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 395 |
Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: Towards targeted therapies. Cell Oncol (Dordr) 2020;43:195-209. [PMID: 31848929 DOI: 10.1007/s13402-019-00488-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 396 |
Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 397 |
Singh P, de Souza P, Scott KF, Hall BM, Verma ND, Becker TM, Toh JWT, Sajinovic M, Spring KJ. Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1? transl med commun 2019;4:2. [DOI: 10.1186/s41231-019-0032-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 398 |
Gottlieb-vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J. Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis. Annals of Surgery 2019;270:1005-17. [DOI: 10.1097/sla.0000000000003252] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 399 |
Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, Butini S, Campiani G. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Med Res Rev 2020;40:1002-60. [PMID: 31742748 DOI: 10.1002/med.21646] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 400 |
Chhabra P, Bhasin DK. Risk assessment for Barrett's esophagus: so near, yet so far! Gastrointest Endosc 2019;90:718-20. [PMID: 31635712 DOI: 10.1016/j.gie.2019.07.024] [Reference Citation Analysis]
|
| 401 |
Hayashi M, Kawakubo H, Fukuda K, Mayanagi S, Nakamura R, Suda K, Hayashida T, Wada N, Kitagawa Y. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5-fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis. J Gene Med 2019;21:e3135. [PMID: 31656051 DOI: 10.1002/jgm.3135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 402 |
Rábeková Z. Future trends in esophageal cancer treatment (prevention, biological therapy, immunotherapy, individualized therapy, novelties in surgery). Klin Farmakol Farm 2019;33:37-40. [DOI: 10.36290/far.2019.021] [Reference Citation Analysis]
|
| 403 |
Fan X, Tao J, Cai Z, Fredimoses M, Wu J, Jiang Z, Zhang K, Li S. Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase. Front Pharmacol 2019;10:1248. [PMID: 31708778 DOI: 10.3389/fphar.2019.01248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 404 |
Onishi S, Tajika M, Tanaka T, Hirayama Y, Hara K, Mizuno N, Kuwahara T, Okuno N, Inaba Y, Kodaira T, Abe T, Muro K, Shimizu M, Niwa Y. Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer. J Clin Med 2019;8:E1647. [PMID: 31601040 DOI: 10.3390/jcm8101647] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 405 |
Chai Y, Li Q, Zhao H, Zhang Z, Yu X, Pang L, Liu Z, Zhao J, Wang L, Li F. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma. Cancer Med 2019;8:7055-64. [PMID: 31560173 DOI: 10.1002/cam4.2569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 406 |
Luo H, Song H, Mao R, Gao Q, Feng Z, Wang N, Song S, Jiao R, Ni P, Ge H. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer Sci 2019;110:3464-75. [PMID: 31454136 DOI: 10.1111/cas.14184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 407 |
Zou LQ, Yang X, Li YD, Zhu ZF. Immune checkpoint inhibitors: a new era for esophageal cancer. Expert Rev Anticancer Ther 2019;19:731-8. [PMID: 31424306 DOI: 10.1080/14737140.2019.1654379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 408 |
Ueki N, Akazawa Y, Miura S, Matsuda K, Kurohama H, Imaizumi T, Kondo H, Nakashima M. Significant association between 53 BP1 expression and grade of intraepithelial neoplasia of esophagus: Alteration during esophageal carcinogenesis. Pathol Res Pract 2019;215:152601. [PMID: 31570283 DOI: 10.1016/j.prp.2019.152601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 409 |
Ehrenhöfer-Wölfer K, Puchner T, Schwarz C, Rippka J, Blaha-Ostermann S, Strobl U, Hörmann A, Bader G, Kornigg S, Zahn S, Sommergruber W, Schweifer N, Zichner T, Schlattl A, Neumüller RA, Shi J, Vakoc CR, Kögl M, Petronczki M, Kraut N, Pearson MA, Wöhrle S. SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines. Sci Rep 2019;9:11661. [PMID: 31406271 DOI: 10.1038/s41598-019-48152-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 410 |
Clemente-Gutiérrez U, Medina-Franco H, Santes O, Morales-Maza J, Alfaro-Goldaracena A, Heslin MJ. Open surgical treatment for esophageal cancer: transhiatal vs. transthoracic, does it really matter? J Gastrointest Oncol 2019;10:783-8. [PMID: 31392059 DOI: 10.21037/jgo.2019.03.12] [Reference Citation Analysis]
|
| 411 |
Zhang C, Wang L, Yang J, Fu Y, Li H, Xie L, Cui Y. MicroRNA-33a-5p suppresses esophageal squamous cell carcinoma progression via regulation of lncRNA DANCR and ZEB1. Eur J Pharmacol 2019;861:172590. [PMID: 31401160 DOI: 10.1016/j.ejphar.2019.172590] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 412 |
Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 2019;25:6170-9. [PMID: 31358543 DOI: 10.1158/1078-0432.CCR-19-0318] [Cited by in Crossref: 50] [Cited by in F6Publishing: 55] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 413 |
Matsui T, Chiyo T, Kobara H, Fujihara S, Fujita K, Namima D, Nakahara M, Kobayashi N, Nishiyama N, Yachida T, Morishita A, Iwama H, Masaki T. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo. Int J Mol Sci 2019;20:E3197. [PMID: 31261874 DOI: 10.3390/ijms20133197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 414 |
Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, Zheng A, Zhou F, Fan R. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep 2019;20:1551-60. [PMID: 31257510 DOI: 10.3892/mmr.2019.10420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 415 |
Kong L, Wu Z, Zhao Y, Lu X, Shi H, Liu S, Li J. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression. Biosci Rep 2019;39:BSR20190850. [PMID: 31110076 DOI: 10.1042/BSR20190850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 416 |
Shi JJ, Xing H, Wang YX, Zhang X, Zhan QM, Geng MY, Ding J, Meng LH. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment. Cancer Lett 2019;459:145-55. [PMID: 31173854 DOI: 10.1016/j.canlet.2019.05.040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 417 |
Peters Y, Al-Kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5:35. [PMID: 31123267 DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
|
| 418 |
Yang Y, Sun X, Chi C, Liu Y, Lin C, Xie D, Shen X, Lin X. Upregulation of long noncoding RNA LINC00152 promotes proliferation and metastasis of esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:4643-54. [PMID: 31191025 DOI: 10.2147/CMAR.S198905] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 419 |
Moon H, Zhu J, Donahue LR, Choi E, White AC. Krt5+/Krt15+ foregut basal progenitors give rise to cyclooxygenase-2-dependent tumours in response to gastric acid stress. Nat Commun 2019;10:2225. [PMID: 31110179 DOI: 10.1038/s41467-019-10194-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 420 |
Yang L, Ye Y, Chu J, Jia J, Qu Y, Sun T, Yin H, Ming L, Wan J, He F. Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway. Cancer Manag Res 2019;11:4425-35. [PMID: 31191005 DOI: 10.2147/CMAR.S196004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 421 |
Hoshino I, Takahashi M, Akutsu Y, Murakami K, Matsumoto Y, Suito H, Sekino N, Komatsu A, Iida K, Suzuki T, Inoue I, Ishige F, Iwatate Y, Matsubara H. Genome-wide ChIP-seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells. Oncol Lett 2019;18:872-81. [PMID: 31289565 DOI: 10.3892/ol.2019.10350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 422 |
Renelus BD, Jamorabo DS, Kancharla P, Paul S, Dave N, Briggs WM, Peterson SJ. Racial Disparities with Esophageal Cancer Mortality at a High-Volume University Affiliated Center: An All ACCESS Invitation. J Natl Med Assoc 2020;112:478-83. [PMID: 31072644 DOI: 10.1016/j.jnma.2019.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 423 |
Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's-associated adenocarcinoma? Biochim Biophys Acta Rev Cancer 2019;1872:188291. [PMID: 31059738 DOI: 10.1016/j.bbcan.2019.04.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 424 |
Januszewicz W, Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma. Medicine (Abingdon) 2019;47:275-85. [PMID: 32467662 DOI: 10.1016/j.mpmed.2019.02.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 425 |
Li J, He D. Long noncoding RNA Xist predicts the presence of lymph node metastases in human oesophageal squamous cell carcinoma. Br J Biomed Sci 2019;76:147-9. [PMID: 30883269 DOI: 10.1080/09674845.2019.1594489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 426 |
Sayır F, Şehitoğulları A, Demir H, Aslan M, Çobanoğlu U, Bilgin C. Serum prolidase activity, total oxidant/antioxidant, and nitric oxide levels in patients with esophageal squamous cell carcinoma. Turk Gogus Kalp Damar Cerrahisi Derg 2019;27:206-11. [PMID: 32082854 DOI: 10.5606/tgkdc.dergisi.2019.16888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 427 |
Liu X, Song M, Wang P, Zhao R, Chen H, Zhang M, Shi Y, Liu K, Liu F, Yang R, Li E, Bode AM, Dong Z, Lee MH. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. Int J Cancer 2019;145:1007-19. [PMID: 30887517 DOI: 10.1002/ijc.32285] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 428 |
Shah MA, Kojima T, Hochhauser D, Enzinger P, Raimbourg J, Hollebecque A, Lordick F, Kim SB, Tajika M, Kim HT, Lockhart AC, Arkenau HT, El-Hajbi F, Gupta M, Pfeiffer P, Liu Q, Lunceford J, Kang SP, Bhagia P, Kato K. Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study. JAMA Oncol 2019;5:546-50. [PMID: 30570649 DOI: 10.1001/jamaoncol.2018.5441] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 429 |
Naffouje SA, Salloum RH, Khalaf Z, Salti GI. Outcomes of Open Versus Minimally Invasive Ivor-Lewis Esophagectomy for Cancer: A Propensity-Score Matched Analysis of NSQIP Database. Ann Surg Oncol. 2019;. [PMID: 30927192 DOI: 10.1245/s10434-019-07319-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 430 |
Wu M, Wang Y, Yang D, Gong Y, Rao F, Liu R, Danna Y, Li J, Fan J, Chen J, Zhang W, Zhan Q. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. EBioMedicine 2019;41:244-55. [PMID: 30876762 DOI: 10.1016/j.ebiom.2019.02.012] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 431 |
Venur VA, Cohen JV, Brastianos PK. Targeting Molecular Pathways in Intracranial Metastatic Disease. Front Oncol 2019;9:99. [PMID: 30886831 DOI: 10.3389/fonc.2019.00099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 432 |
Januszewicz W, Fitzgerald RC. Early detection and therapeutics. Mol Oncol. 2019;13:599-613. [PMID: 30677217 DOI: 10.1002/1878-0261.12458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 433 |
Frankell AM, Jammula S, Li X, Contino G, Killcoyne S, Abbas S, Perner J, Bower L, Devonshire G, Ococks E, Grehan N, Mok J, O'Donovan M, MacRae S, Eldridge MD, Tavaré S, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nat Genet 2019;51:506-16. [PMID: 30718927 DOI: 10.1038/s41588-018-0331-5] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 28.5] [Reference Citation Analysis]
|
| 434 |
Shen FF, Pan Y, Li JZ, Zhao F, Yang HJ, Li JK, Gao ZW, Su JF, Duan LJ, Lun SM, Zhang P, Tian LQ, Sun G, Huang D, Cao YT, Zhou FY. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China. Medicine (Baltimore) 2019;98:e14454. [PMID: 30813145 DOI: 10.1097/MD.0000000000014454] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 435 |
Xi L, Zhu J, Zhang H, Muktiali M, Xu C, Wu A. Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study. Dig Dis Sci 2019;64:532-43. [PMID: 30350242 DOI: 10.1007/s10620-018-5335-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 436 |
Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, Asari R, Schoppmann SF. High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma. Ann Surg Oncol 2019;26:976-85. [PMID: 30706229 DOI: 10.1245/s10434-019-07186-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 437 |
Cools-lartigue J, Ferri L. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer? Ann Surg Oncol 2019;26:1014-27. [DOI: 10.1245/s10434-019-07162-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 438 |
Gill MR, Menon JU, Jarman PJ, Owen J, Skaripa-Koukelli I, Able S, Thomas JA, Carlisle R, Vallis KA. 111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells. Nanoscale 2018;10:10596-608. [PMID: 29808844 DOI: 10.1039/c7nr09606b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 439 |
Mizumoto A, Ohashi S, Kamada M, Saito T, Nakai Y, Baba K, Hirohashi K, Mitani Y, Kikuchi O, Matsubara J, Yamada A, Takahashi T, Lee H, Okuno Y, Kanai M, Muto M. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma. J Gastroenterol 2019;54:687-98. [PMID: 30737573 DOI: 10.1007/s00535-019-01549-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 440 |
Chénard-poirier M, Smyth EC. Gastric Cancers. Oncogenomics 2019. [DOI: 10.1016/b978-0-12-811785-9.00017-x] [Reference Citation Analysis]
|
| 441 |
Munari FF, Cruvinel-Carloni A, Lacerda CF, de Oliveira ATT, Scapulatempo-Neto C, da Silva SRM, Crema E, Adad SJ, Rodrigues MAM, Henry MACA, Guimarães DP, Longatto-Filho A, Reis RM. PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome. Infect Agent Cancer 2018;13:43. [PMID: 30619505 DOI: 10.1186/s13027-018-0216-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 442 |
Cao JX, Lu Y. Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma. Onco Targets Ther 2019;12:63-74. [PMID: 30588031 DOI: 10.2147/OTT.S183629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 443 |
Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, Cemazar M, Valpione S, Miklavčič D, Mocellin S, Sieni E, Sersa G. Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019;45:92-102. [PMID: 30528893 DOI: 10.1016/j.ejso.2018.11.023] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 444 |
Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 445 |
Wang Y, Zhu L, Xia W, Wang F. Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer. Cancer Manag Res. 2018;10:6295-6303. [PMID: 30568491 DOI: 10.2147/cmar.s182436] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 446 |
Wang L, Dong G, Xia W, Mao Q, Wang A, Chen B, Ma W, Wu Y, Xu L, Jiang F. Integrative analysis of differential genes and identification of a "2-gene score" associated with survival in esophageal squamous cell carcinoma. Thorac Cancer 2019;10:60-70. [PMID: 30421504 DOI: 10.1111/1759-7714.12902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 447 |
Wang Y, Zhu L, Xia W, Wu L, Wang F. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma. World J Surg Oncol 2018;16:216. [PMID: 30404621 DOI: 10.1186/s12957-018-1516-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 448 |
Chai J. Introductory Chapter: Esophagus and Esophageal Cancer. Esophageal Cancer and Beyond 2018. [DOI: 10.5772/intechopen.77995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 449 |
Fu C, Li J, Aipire A, Xia L, Yang Y, Chen Q, Lv J, Wang X, Li J. Cistanche tubulosa phenylethanoid glycosides induce apoptosis in Eca-109 cells via the mitochondria-dependent pathway. Oncol Lett 2019;17:303-13. [PMID: 30655768 DOI: 10.3892/ol.2018.9635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 450 |
Fan G, Hu D, Zhang X, Peng F, Lin X, Chen G, Liang B, Zhang H, Xia Y, Zheng X, Jie J, Niu W. Interaction Between Prediabetes and the ABO Blood Types in Predicting Postsurgical Esophageal Squamous Cell Carcinoma-Specific Mortality: The FIESTA Study. Front Oncol 2018;8:461. [PMID: 30406028 DOI: 10.3389/fonc.2018.00461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 451 |
Zhang Y, Liu YD, Luo YL, Liu BL, Huang QT, Wang F, Zhong Q. Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma. J Cancer 2018;9:4287-93. [PMID: 30519331 DOI: 10.7150/jca.26949] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 452 |
Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C. Prognostic factors in esophageal cancer treated with curative intent. Dig Liver Dis 2018;50:991-6. [PMID: 30166221 DOI: 10.1016/j.dld.2018.08.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 453 |
Yuan L, Hider P, Walsh M, Srinivasa S, Rodgers M, Booth M, Grant M, Brown A, Koea J. Oesophagectomy at a New Zealand regional centre: where to now?: Oesophagectomy in New Zealand. ANZ Journal of Surgery 2018;88:1269-73. [DOI: 10.1111/ans.14563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 454 |
D'Journo XB. Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis 2018;10:S2671-81. [PMID: 30345104 DOI: 10.21037/jtd.2018.03.182] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 455 |
Li X, Francies HE, Secrier M, Perner J, Miremadi A, Galeano-Dalmau N, Barendt WJ, Letchford L, Leyden GM, Goffin EK, Barthorpe A, Lightfoot H, Chen E, Gilbert J, Noorani A, Devonshire G, Bower L, Grantham A, MacRae S, Grehan N, Wedge DC, Fitzgerald RC, Garnett MJ. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics. Nat Commun 2018;9:2983. [PMID: 30061675 DOI: 10.1038/s41467-018-05190-9] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 456 |
Fitzgerald RC. Organ-preserving approaches in oesophageal cancer. Lancet Oncol 2018;19:858-9. [PMID: 29861117 DOI: 10.1016/S1470-2045(18)30291-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 457 |
Du D, Song T, Dai H, Jing Z, Chen P, Wu S. Stereotactic body radiation therapy and thymosin alpha-1-induced anti-tumor effects in heavily pretreated, metastatic esophageal squamous cell carcinoma patients. Oncoimmunology 2018;7:e1450128. [PMID: 30221039 DOI: 10.1080/2162402X.2018.1450128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 458 |
Nicolau-Neto P, Da Costa NM, de Souza Santos PT, Gonzaga IM, Ferreira MA, Guaraldi S, Moreira MA, Seuánez HN, Brewer L, Bergmann A, Boroni M, Mencalha AL, Kruel CDP, Lima SCS, Esposito D, Simão TA, Pinto LFR. Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway. Oncotarget 2018;9:16634-47. [PMID: 29682174 DOI: 10.18632/oncotarget.24621] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 459 |
van Putten M, de Vos-Geelen J, Nieuwenhuijzen GAP, Siersema PD, Lemmens VEPP, Rosman C, van der Sangen MJC, Verhoeven RHA. Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer. 2018;94:138-147. [PMID: 29571082 DOI: 10.1016/j.ejca.2018.02.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 460 |
Hewitt LC, Inam IZ, Saito Y, Yoshikawa T, Quaas A, Hoelscher A, Bollschweiler E, Fazzi GE, Melotte V, Langley RE, Nankivell M, Cunningham D, Allum W, Hutchins GG, Grabsch HI. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study. Eur J Cancer 2018;94:104-14. [PMID: 29550565 DOI: 10.1016/j.ejca.2018.02.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 461 |
Yuan H, Zhou W, Yang Y, Xue L, Liu L, Song Y. ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/β-catenin signaling pathway. Exp Cell Res 2018;367:47-55. [PMID: 29555370 DOI: 10.1016/j.yexcr.2018.03.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 462 |
Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 2018;122:179-93. [PMID: 29458786 DOI: 10.1016/j.critrevonc.2017.12.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 463 |
O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 464 |
Boshier PR, Wirsching A, Low DE. Esophageal Cancer. A Mastery Approach to Complex Esophageal Diseases 2018. [DOI: 10.1007/978-3-319-75795-7_13] [Reference Citation Analysis]
|
| 465 |
Szymańska K. Esophageal Cancer. Diagnosis and Treatment. Reference Module in Biomedical Sciences 2018. [DOI: 10.1016/b978-0-12-801238-3.65301-1] [Reference Citation Analysis]
|
| 466 |
Michalarea V, Smyth EC. Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma. J Thorac Dis 2017;9:2868-70. [PMID: 29221258 DOI: 10.21037/jtd.2017.08.148] [Reference Citation Analysis]
|
| 467 |
Cartwright E, Cunningham D. The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer. Curr Treat Options Oncol 2017;18:69. [PMID: 29143893 DOI: 10.1007/s11864-017-0510-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 468 |
Gill MR, Jarman PJ, Halder S, Walker MG, Saeed HK, Thomas JA, Smythe C, Ramadan K, Vallis KA. A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(ii) metallo-intercalator. Chem Sci 2018;9:841-9. [PMID: 29629151 DOI: 10.1039/c7sc03712k] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 469 |
Yu Q, Liu Y, Wen C, Zhao Y, Jin S, Hu Y, Wang F, Chen L, Zhang B, Wang W, Zhu Q, Guo R. MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib. Oncol Lett 2018;15:963-71. [PMID: 29399158 DOI: 10.3892/ol.2017.7378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 470 |
Lordick F. Treatment of oesophageal cancer - Stressing the patient perspective. Eur J Cancer 2017;84:360-2. [PMID: 28942866 DOI: 10.1016/j.ejca.2017.08.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 471 |
Testa U, Castelli G, Pelosi E. Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. Medicines (Basel) 2017;4:E67. [PMID: 28930282 DOI: 10.3390/medicines4030067] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 472 |
[DOI: 10.1101/454306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 473 |
[DOI: 10.1101/310029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
